Aliases & Classifications for Pouchitis

MalaCards integrated aliases for Pouchitis:

Name: Pouchitis 59 55 17 72

Characteristics:

Orphanet epidemiological data:

59
pouchitis
Prevalence: 1-5/10000 (Europe);

Classifications:



External Ids:

MESH via Orphanet 45 D019449
UMLS via Orphanet 73 C0376620
Orphanet 59 ORPHA217067
UMLS 72 C0376620

Summaries for Pouchitis

MalaCards based summary : Pouchitis is related to ileitis and crohn's colitis. An important gene associated with Pouchitis is NOD2 (Nucleotide Binding Oligomerization Domain Containing 2), and among its related pathways/superpathways are Innate Immune System and Cytokine Signaling in Immune system. The drugs Ciprofloxacin and Vedolizumab have been mentioned in the context of this disorder. Affiliated tissues include colon, liver and small intestine.

Wikipedia : 75 Pouchitis is inflammation of the ileal pouch (an artificial rectum surgically created out of ileal gut... more...

Related Diseases for Pouchitis

Diseases related to Pouchitis via text searches within MalaCards or GeneCards Suite gene sharing:

(showing 191, show less)
# Related Disease Score Top Affiliating Genes
1 ileitis 31.4 TLR4 NOD2
2 crohn's colitis 30.6 NOD2 CXCL8
3 pyoderma 30.5 NOD2 CXCL8
4 pyoderma gangrenosum 30.5 NOD2 CXCL8
5 ulcerative colitis 30.2 TLR4 NOD2 IL10 CXCL8
6 spondyloarthropathy 1 30.1 TLR4 NOD2
7 spondylitis 30.0 NOD2 IL1RN
8 colitis 29.9 TLR4 NOD2 IL10 CXCL8
9 inflammatory bowel disease 29.6 TLR4 NOD2 IL10 CXCL8
10 appendicitis 29.5 IL10 CXCL8
11 uveitis 29.5 NOD2 IL10
12 peritonitis 29.2 IL10 CXCL8
13 arthritis 28.8 NOD2 IL1RN IL10 CXCL8
14 proteasome-associated autoinflammatory syndrome 1 28.7 TLR4 IL1RN IL10 CXCL8
15 familial adenomatous polyposis 10.8
16 crohn's disease 10.7
17 sclerosing cholangitis 10.5
18 cholangitis 10.5
19 cholangitis, primary sclerosing 10.5
20 overgrowth syndrome 10.5
21 papillomatosis, confluent and reticulated 10.4
22 diarrhea 10.4
23 hypersensitivity reaction type iv disease 10.3 NOD2 IL1RN
24 spondylarthropathy 10.3 TLR4 NOD2
25 inflammatory bowel disease 6 10.3 TLR4 NOD2
26 pediatric ulcerative colitis 10.3
27 cytomegalovirus infection 10.3
28 neisseria meningitidis infection 10.3 TLR4 IL1RN
29 sapho syndrome 10.2 NOD2 CXCL8
30 peripheral nervous system disease 10.2
31 neuropathy 10.2
32 necrotizing fasciitis 10.2 IL1RN CXCL8
33 familial mediterranean fever 10.2 NOD2 IL1RN
34 proctitis 10.2
35 cytokine deficiency 10.2
36 giant papillary conjunctivitis 10.1 LTF CXCL8
37 felty syndrome 10.1 LTF CXCL8
38 haemophilus influenzae 10.1 LTF CXCL8
39 superficial urinary bladder cancer 10.1 TLR4 CXCL8
40 periodontosis 10.1 TLR4 CXCL8
41 bronchopulmonary dysplasia 10.1 IL1RN CXCL8
42 pyelitis 10.1 TLR4 CXCL8
43 endometrial disease 10.1 TLR4 CXCL8
44 gastric ulcer 10.1 IL1RN CXCL8
45 bacteriuria 10.1 TLR4 CXCL8
46 septic arthritis 10.1 TLR4 CXCL8
47 oral candidiasis 10.1 LTF CXCL8
48 middle ear disease 10.1 TLR4 CXCL8
49 perinatal necrotizing enterocolitis 10.1 TLR4 CXCL8
50 silicosis 10.1 IL1RN CXCL8
51 invasive aspergillosis 10.1 TLR4 CXCL8
52 deficiency anemia 10.1
53 exanthem 10.1
54 collagenous colitis 10.1
55 diversion colitis 10.1
56 megacolon 10.1
57 iritis 10.1
58 toxic megacolon 10.1
59 adenocarcinoma 10.1
60 colonic disease 10.1
61 gastroduodenitis 10.1
62 cluster headache 10.1
63 undetermined colitis 10.1
64 atrophic gastritis 10.1 IL1RN CXCL8
65 bacterial vaginosis 10.1 TLR4 CXCL8
66 duodenal ulcer 10.0 IL1RN CXCL8
67 bacterial pneumonia 10.0 TLR4 CXCL8
68 orofacial granulomatosis 10.0 NOD2 IL10
69 gaucher disease, type ii 10.0 IL1RN IL10
70 acute graft versus host disease 10.0 NOD2 IL10
71 leprosy 3 10.0 NOD2 IL10
72 uveal disease 10.0 NOD2 IL10
73 gingivitis 10.0 LTF CXCL8
74 extrapulmonary tuberculosis 10.0 IL1RN IL10
75 aphthous stomatitis 10.0 IL1RN IL10
76 coccidioidomycosis 9.9 TLR4 IL10
77 cystic echinococcosis 9.9 TLR4 IL10
78 echinococcosis 9.9 TLR4 IL10
79 familial adenomatous polyposis 1 9.9
80 prostate cancer 9.9
81 anemia, autoimmune hemolytic 9.9
82 multinucleated neurons, anhydramnios, renal dysplasia, cerebellar hypoplasia, and hydranencephaly 9.9
83 body mass index quantitative trait locus 1 9.9
84 alpha/beta t-cell lymphopenia with gamma/delta t-cell expansion, severe cytomegalovirus infection, and autoimmunity 9.9
85 gastrointestinal ulceration, recurrent, with dysfunctional platelets 9.9
86 autoimmune pancreatitis 9.9
87 sleep apnea 9.9
88 microscopic colitis 9.9
89 lymphocytic colitis 9.9
90 anal fistula 9.9
91 non-alcoholic fatty liver disease 9.9
92 igg4-related disease 9.9
93 respiratory failure 9.9
94 spondyloarthropathy 9.9
95 iron deficiency anemia 9.9
96 inflammatory spondylopathy 9.9
97 frozen shoulder 9.9
98 enthesopathy 9.9
99 thrombocytosis 9.9
100 iron metabolism disease 9.9
101 bursitis 9.9
102 acute kidney failure 9.9
103 ischemia 9.9
104 plague 9.9
105 hemolytic anemia 9.9
106 adenoma 9.9
107 skin tag 9.9
108 ileus 9.9
109 duodenitis 9.9
110 fatty liver disease 9.9
111 irritable bowel syndrome 9.9
112 central serous chorioretinopathy 9.9
113 hemorrhagic proctocolitis 9.9
114 radiation proctitis 9.9
115 pik3ca-related overgrowth syndrome 9.9
116 scrub typhus 9.9 TLR4 IL10
117 aspergillosis 9.9 TLR4 IL10
118 extrinsic cardiomyopathy 9.9 TLR4 IL10
119 meningitis 9.9 IL10 CXCL8
120 keratoconjunctivitis sicca 9.9 LTF IL10
121 paracoccidioidomycosis 9.9 TLR4 IL10
122 cystitis 9.9 TLR4 CXCL8
123 tungiasis 9.9 IL10 CXCL8
124 acute transverse myelitis 9.9 IL10 CXCL8
125 transverse myelitis 9.9 IL10 CXCL8
126 neurosyphilis 9.9 IL10 CXCL8
127 scabies 9.9 IL10 CXCL8
128 vulvovaginitis 9.9 IL10 CXCL8
129 necatoriasis 9.9 IL10 CXCL8
130 melioidosis 9.9 TLR4 IL10
131 funisitis 9.8 IL10 CXCL8
132 clonorchiasis 9.8 IL10 CXCL8
133 retinitis pigmentosa 44 9.8 IL10 CXCL8
134 mycetoma 9.8 IL10 CXCL8
135 radiculopathy 9.8 IL10 CXCL8
136 filariasis 9.8 TLR4 IL10
137 primary peritoneal carcinoma 9.8 IL10 CXCL8
138 acute pyelonephritis 9.8 IL10 CXCL8
139 viral encephalitis 9.8 IL10 CXCL8
140 prostatitis 9.8 IL10 CXCL8
141 synovitis 9.8 IL1RN CXCL8
142 mastitis 9.8 NOD2 LTF CXCL8
143 nose disease 9.8 IL10 CXCL8
144 leptospirosis 9.8 IL10 CXCL8
145 cutaneous leishmaniasis 9.7 TLR4 IL10
146 bronchiolitis obliterans 9.7 IL10 CXCL8
147 dengue hemorrhagic fever 9.7 IL10 CXCL8
148 adult respiratory distress syndrome 9.7 IL10 CXCL8
149 extrinsic allergic alveolitis 9.7 IL10 CXCL8
150 chorioamnionitis 9.7 TLR4 IL1RN CXCL8
151 allergic contact dermatitis 9.7 IL10 CXCL8
152 contact dermatitis 9.7 IL10 CXCL8
153 bacterial meningitis 9.7 IL10 CXCL8
154 pulmonary edema 9.7 IL10 CXCL8
155 upper respiratory tract disease 9.7 IL10 CXCL8
156 gastroenteritis 9.7 IL10 CXCL8
157 toxoplasmosis 9.7 TLR4 IL10
158 endocarditis 9.6 IL10 CXCL8
159 alcoholic hepatitis 9.6 IL10 CXCL8
160 bronchial disease 9.6 IL10 CXCL8
161 q fever 9.6 TLR4 NOD2 IL10
162 idiopathic neutropenia 9.5 TLR4 IL1RN IL10
163 trypanosomiasis 9.5 IL10 CXCL8
164 aseptic meningitis 9.5 IL1RN IL10 CXCL8
165 peptic ulcer disease 9.4 IL1RN IL10 CXCL8
166 osteomyelitis 9.4 IL1RN IL10 CXCL8
167 bone inflammation disease 9.4 IL1RN IL10 CXCL8
168 periodontitis 9.4 TLR4 IL10 CXCL8
169 bacterial sepsis 9.4 TLR4 IL10 CXCL8
170 pyelonephritis 9.4 TLR4 IL10 CXCL8
171 shigellosis 9.4 LTF IL10 CXCL8
172 primary bacterial infectious disease 9.4 TLR4 IL10 CXCL8
173 visceral leishmaniasis 9.4 TLR4 IL10 CXCL8
174 toxic shock syndrome 9.4 TLR4 IL10 CXCL8
175 chlamydia 9.4 TLR4 IL10 CXCL8
176 bronchiolitis 9.4 TLR4 IL10 CXCL8
177 mouth disease 9.4 TLR4 IL10
178 otitis media 9.4 TLR4 IL10 CXCL8
179 chagas disease 9.4 TLR4 IL10 CXCL8
180 respiratory system disease 9.4 TLR4 IL10 CXCL8
181 pneumonia 9.4 TLR4 IL10 CXCL8
182 omenn syndrome 9.3 IL1RN IL10
183 lymphadenitis 9.0 TLR4 NOD2 IL10 CXCL8
184 intestinal disease 9.0 TLR4 NOD2 IL10 CXCL8
185 bacterial infectious disease 9.0 TLR4 NOD2 IL10 CXCL8
186 brucellosis 9.0 TLR4 IL1RN IL10 CXCL8
187 rheumatoid arthritis 8.9 TLR4 IL1RN IL10 CXCL8
188 malaria 8.9 TLR4 IL1RN IL10 CXCL8
189 behcet syndrome 8.6 TLR4 NOD2 IL1RN IL10 CXCL8
190 gastrointestinal system disease 8.5 TLR4 NOD2 LTF IL10 CXCL8
191 aggressive periodontitis 8.5 TLR4 LTF IL1RN IL10 CXCL8

Graphical network of the top 20 diseases related to Pouchitis:



Diseases related to Pouchitis

Symptoms & Phenotypes for Pouchitis

Drugs & Therapeutics for Pouchitis

Drugs for Pouchitis (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(showing 36, show less)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Ciprofloxacin Approved, Investigational Phase 4 85721-33-1 2764
2 Vedolizumab Approved Phase 4 943609-66-3
3 Acidophilus Phase 4
4 Gastrointestinal Agents Phase 4
5 Cytochrome P-450 Enzyme Inhibitors Phase 4
6 Topoisomerase Inhibitors Phase 4
7 Cytochrome P-450 CYP1A2 Inhibitors Phase 4
8
Adalimumab Approved Phase 3 331731-18-1 16219006
9
Ursodeoxycholic acid Approved, Investigational Phase 2, Phase 3 128-13-2 31401
10
Valganciclovir Approved, Investigational Phase 3 175865-60-8 64147
11
Alicaforsen Investigational Phase 3 185229-68-9 16197724
12 Liver Extracts Phase 3
13 Anti-Inflammatory Agents Phase 3
14 Cholagogues and Choleretics Phase 2, Phase 3
15 Bile Acids and Salts Phase 2, Phase 3
16 Anti-Infective Agents Phase 3
17 Antiviral Agents Phase 3
18
Clotrimazole Approved, Vet_approved Phase 1, Phase 2 23593-75-1 2812
19 Antibiotics, Antitubercular Phase 2
20 Anti-Bacterial Agents Phase 1, Phase 2
21 Antitubercular Agents Phase 2
22
Scopolamine Approved, Investigational 6533-68-2, 51-34-3 5184
23
Infliximab Approved 170277-31-3
24
Ethanol Approved 64-17-5 702
25
Certolizumab pegol Approved 428863-50-7
26
Inulin Approved, Investigational, Nutraceutical 9005-80-5 24763
27 Defensins
28 Butylscopolammonium Bromide
29 Bifidobacterium
30 Antibodies
31 Immunoglobulins
32 Chicory
33 Dermatologic Agents
34 Antirheumatic Agents
35 Immunologic Factors
36 Immunosuppressive Agents

Interventional clinical trials:

(showing 40, show less)
# Name Status NCT ID Phase Drugs
1 Double-blind Placebo Controlled Trial of VSL#3 in Children With Crohn's Disease Unknown status NCT00367705 Phase 4
2 Bacteria and Cytokines as Factors Modulating Visceral Afferent Processing in Irritable Bowel Syndrome: Manipulation of Intestinal Bacteria and Mucosal Cytokines by Probiotic Therapy and the Effect on Visceral Hypersensitivity Unknown status NCT00418340 Phase 4 probiotic (bacterial/dietary supplement)
3 Lactobacillus Reuteri Reduces Pulmonary Exacerbations and Upper Respiratory Tract Infections in CF Patients With Mild-to-moderate Lung Disease. LR Administration Might Have a Beneficial Effect on the Disease Course of Cystic Fibrosis. Completed NCT01737983 Phase 4
4 Randomized, Double-Blind, Placebo-Controlled Study of VSL#3 Versus Placebo in the Maintenance of Remission in Crohn's Disease Completed NCT00114465 Phase 4 VSL#3
5 A Randomized, Double-Blind, Placebo-Controlled Phase 4 Study to Evaluate the Efficacy and Safety of Entyvio (Vedolizumab IV) in the Treatment of Chronic Pouchitis (EARNEST) Recruiting NCT02790138 Phase 4 Vedolizumab;Ciprofloxacin;Vedolizumab Placebo
6 Probiotics in Patients With Primary Sclerosing Cholangitis and Inflammatory Bowel Disease- a Randomized Placebo-Controlled Cross-Over Trial Unknown status NCT00161148 Phase 3 Probiotics
7 Adalimumab (Humira) in the Treatment of Chronic Pouchitis Completed NCT01670240 Phase 3 Adalimumab;Placebo
8 A Randomized, Double-Blind, Placebo-Controlled Trial of the Safety and Efficacy of Topical Alicaforsen Enema in Subjects With Active, Chronic, Antibiotic Refractory Primary Idiopathic Pouchitis Completed NCT02525523 Phase 3 Alicaforsen;Placebo
9 Clinical Approaches to Ileal Pouch Dysfunction Completed NCT00293553 Phase 3
10 Prospective Multicenter Randomized Controlled Double-blind Label Study of the Prophylaxis of Recurrent Pouchitis After Fecal Microbiota Transplant in UC With Ileo-anal Anastomosis Recruiting NCT03524352 Phase 3
11 The Role of Secondary Bile Acids in Intestinal Inflammation Recruiting NCT03724175 Phase 2, Phase 3 ursodiol (ursodeoxycholic acid, UDCA)
12 Relevance of Valganciclovir in Recurrent Bouts of Cryptogenic Inflammatory Bowel Diseases With an Infection by Cytomegalovirus Terminated NCT00237653 Phase 3 Valganciclovir
13 To Determine the Effect of Honey Enema in the Treatment of Patients With Acute Pouchitis (Pilot Study) Completed NCT02201186 Phase 2
14 The Use of Fecal Microbiota Transplantation in Patients With Ulcerative Colitis-associated Pouchitis Completed NCT02049502 Phase 2
15 A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Active Pouchitis Completed NCT00583076 Phase 2 AST-120
16 A Randomized Double-Blind Trial of Perioperative Administration of Probiotics in Colorectal Cancer Patients. Completed NCT00936572 Phase 2
17 Randomized Trial of Fecal Microbiota Transplantation Versus Placebo for the Induction of Remission in Patients With Active Pouchitis Recruiting NCT03545386 Phase 2
18 Double-blinded Randomized Placebo Controlled Study: Fecal Microbiota Transplantation in the Treatment of Chronic Pouchitis Active, not recruiting NCT03378921 Phase 2
19 Clotrimazole Enemas for Pouchitis in Children and Adults Suspended NCT00061282 Phase 1, Phase 2 Clotrimazole
20 A Pilot Study of the Safety and Efficacy of AST-120 in the Treatment of Antibiotic-Refractory Pouchitis Terminated NCT00583531 Phase 2 AST-120
21 Safety and Efficacy of Fecal Microbiome Transplantation (FMT) in the Treatment of Antibiotic Dependent Pouchitis (ADP) Terminated NCT02782325 Phase 1, Phase 2
22 Prevention of Pouchitis With Short-Chain Fructooligosaccharide Therapy, A Double-Blind, Placebo-Controlled Trial Active, not recruiting NCT02203955 Phase 1 Short-Chain Fructooligosaccharide;Maltodextrin
23 The Interaction Between the Intestinal Microbiota, Innate Defense and Epithelial Integrity in the Development of Pouchitis: a Multifactorial Approach Unknown status NCT01202396
24 Microbiota and Immune microEnvironment in Pouchitis: Randomized Controlled Trial Oral Administration of Lactobacillus Casei DG After Ileostomy Closure in Ileal Pouch Mucosa Unknown status NCT03136419
25 Pelvic Collections on MRI in Patients With Ileal Pouches, and a Feasibility Study of Dynamic MRI Enema and Defaecating MRI Pouchography Unknown status NCT02925260
26 Title Effect of Microbial Translocation and Supplementation With the Probiotic VSL#3 on Neuro-cognitive Functions of HIV Positive Patients Receiving HAART Unknown status NCT02276326
27 Fecal Transplantation for the Treatment of Chronic Pouchitis - A Pilot Study Completed NCT03538366
28 Fecal Microbiota Transplant (FMT) for Pouchitis Completed NCT02428361 Early Phase 1 Biologically active human fecal material, OpenBiome
29 Evaluating the Nutritional Impact of Serum-Derived Bovine Immunoglobulin Protein Isolate in Subjects With Ileal Pouch-Anal Anastomosis Completed NCT02828410
30 Ileal Pouch-anal Anastomosis or Ileo-rectal Anastomosis for Patients With Ulcerative Colitis and Primary Sclerosing Cholangitis? Completed NCT01798953
31 Critical Assessment of Routine Surveillance of Asymptomatic Patients With Ulcerative Colitis With Ileal Pouch-anal Anastomosis and Risk Factors for Dysplasia - is There a Rationale? Completed NCT01764542
32 Ileal Pouch Salvage and Excision Operations: Indications, Complications and Outcomes Completed NCT03952195
33 A Pilot Study of Oral Probiotic Bacteria Supplementation to Reduce Microbial Translocation and Chronic Immune Activation in HIV-infected Malian Women Completed NCT02448238
34 Open-Label Trial of a Prebiotic Preparation Containing Inulin and Oligofructose (Synergy-1) for the Treatment of Mild to Moderate Acute Ulcerative Colitis Completed NCT02093767
35 Correlation of Infliximab Levels With Outcomes in Ulcerative Colitis Recruiting NCT02438410
36 The Effect of VSL#3 (Original De Simone Formulation) Probiotic Preparation on the Bile Acid Metabolism in Patients With Inflammatory Bowel Disease Recruiting NCT01765439
37 Hyperbaric Oxygen Therapy for Antibiotic Refractory Pouchitis: a Phase 2A Clinical Trial Not yet recruiting NCT03526796
38 Epidemiologic, Clinical, Endoscopic and Histological Database of Patients With Inflammatory Bowel Disease (IBD) Not yet recruiting NCT01266538
39 Safety and Efficacy of Fecal Microbiota Transplantation: A Pilot Study Not yet recruiting NCT04014413
40 EUS Evaluation of Perianal and Peri-rectal Fistulizing Crohn's Disease With CERTOLIZUMAB Treatment Terminated NCT01582568 Certolizumab

Search NIH Clinical Center for Pouchitis

Inferred drug relations via UMLS 72 / NDF-RT 51 :


Metronidazole

Genetic Tests for Pouchitis

Anatomical Context for Pouchitis

MalaCards organs/tissues related to Pouchitis:

41
Colon, Liver, Small Intestine, Testes, Lung, Neutrophil, Prostate

Publications for Pouchitis

Articles related to Pouchitis:

(showing 1414, show less)
# Title Authors PMID Year
1
Barrier dysfunction due to distinct defensin deficiencies in small intestinal and colonic Crohn's disease. 9 38
19079235 2008
2
Pouch-ouch. 9 38
18043236 2008
3
The assessment of a rapid noninvasive immunochromatographic assay test for fecal lactoferrin in patients with suspected inflammation of the ileal pouch. 9 38
18085334 2008
4
Pilot study on the effect of reducing dietary FODMAP intake on bowel function in patients without a colon. 9 38
17828776 2007
5
Differential expression of toll-like receptor 3 and 5 in ileal pouch mucosa of ulcerative colitis patients. 9 38
16770571 2007
6
The expression patterns of Toll-like receptors in the ileal pouch mucosa of postoperative ulcerative colitis patients. 9 38
16493544 2006
7
Combined carriership of TLR9-1237C and CD14-260T alleles enhances the risk of developing chronic relapsing pouchitis. 9 38
16437636 2005
8
Innate immune receptor genetic polymorphisms in pouchitis: is CARD15 a susceptibility factor? 9 38
16239841 2005
9
Fecal lactoferrin for diagnosis of symptomatic patients with ileal pouch-anal anastomosis. 9 38
15131788 2004
10
Biliary lactoferrin concentrations are increased in active inflammatory bowel disease: a factor in the pathogenesis of primary sclerosing cholangitis? 9 38
9791051 1998
11
Impact of paediatric onset primary sclerosing cholangitis on clinical course and outcome of inflammatory bowel disease: a case-control population-based study in Finland. 38
31402720 2019
12
Early Experience with Variant Two-Stage Approach in Surgical Management of Inflammatory Bowel Disease Colitis in the Pediatric Population. 38
31403384 2019
13
Long-term bowel function and fate of the ileal pouch after restorative proctocolectomy in patients with Crohn's disease. A systematic review with meta-analysis and metaregression. 38
31412119 2019
14
Efficacy of Vedolizumab for Refractory Pouchitis of the Ileo-anal Pouch: Results From a Multicenter US Cohort. 38
30810748 2019
15
Ulcerative Colitis and Crohn's Disease Have the Same Burden and Goals for Treatment. 38
31301452 2019
16
Prevention And Medical Treatment Of Pouchitis In Ulcerative Colitis. 38
31333137 2019
17
Current surgical practice in pediatric ulcerative colitis: A systematic review. 38
30241963 2019
18
Real-World Experience with Tofacitinib in IBD at a Tertiary Center. 38
30734234 2019
19
Complications after proctocolectomy and ileal pouch-anal anastomosis in pediatric patients: A systematic review. 38
30291026 2019
20
Pouchitis in pediatric ulcerative colitis: A multicenter study on behalf of Italian Society of Pediatric Gastroenterology, Hepatology and Nutrition. 38
31324473 2019
21
The Structure and Function of the Human Small Intestinal Microbiota: Current Understanding and Future Directions. 38
31344510 2019
22
Identifying Outcomes in Clinical Trials of Pouchitis for the Development of a Core Outcome Set. 38
30268563 2019
23
Fecal Microbiota Transplantation in Pouchitis: Clinical, Endoscopic, Histologic, and Microbiota Results from a Pilot Study. 38
31302808 2019
24
Characterization of risk factors for floppy pouch complex in ulcerative colitis. 38
30972491 2019
25
Morbidity related to diverting ileostomy after restorative proctocolectomy in patients with ulcerative colitis. 38
30698869 2019
26
Predictors for Pouchitis After Ileal Pouch-Anal Anastomosis for Pediatric-Onset Ulcerative Colitis. 38
30743232 2019
27
Short- and Long-term Outcomes After Ileal Pouch Anal Anastomosis in Pediatric Patients: A Systematic Review. 38
30668719 2019
28
Ustekinumab Is Effective for the Treatment of Chronic Antibiotic-Refractory Pouchitis. 38
31187322 2019
29
De Novo Crohn Disease of the Pouch in Children Undergoing Ileal Pouch-Anal Anastomosis for Ulcerative Colitis. 38
31136563 2019
30
Does Age Affect Surgical Outcomes After Ileal Pouch-Anal Anastomosis in Children? 38
30710880 2019
31
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. 38
31136680 2019
32
Dual arterial blood supply D-pouch in a patient with ulcerative colitis undergoing proctocolectomy and ileal pouch-anal anastomosis: A case report. 38
31045791 2019
33
Fecal Proteases from Pouchitis Patients Activate Protease Activating Receptor-2 to Disrupt the Epithelial Barrier. 38
31056700 2019
34
Combined Endoscopic and Oral Fecal Microbiota Transplantation in Patients with Antibiotic-Dependent Pouchitis: Low Clinical Efficacy due to Low Donor Microbial Engraftment. 38
31172007 2019
35
Mucosa-Associated Microbiota in Ileoanal Pouches May Contribute to Clinical Symptoms, Particularly Stool Frequency, Independent of Endoscopic Disease Activity. 38
31117112 2019
36
The efficacy of fecal microbiota transplantation for patients with chronic pouchitis: A case series. 38
30997086 2019
37
How do you treat this diversion ileitis and pouchitis? 38
29588334 2019
38
Vedolizumab for chronic antibiotic-refractory pouchitis. 38
30976425 2019
39
Difference in the frequency of pouchitis between ulcerative colitis and familial adenomatous polyposis: is the explanation in peripouch fat? 38
30985958 2019
40
SATB2 and Hep Par 1 Immunohistochemistry Is Helpful in Distinguishing Between Inflamed and Architecturally Altered Ileal Pouch and Rectal Cuff Mucosa. 38
30192165 2019
41
The Effect of Biologics on Postoperative Complications in Children With Inflammatory Bowel Disease and Bowel Resection. 38
30247424 2019
42
Starch Consumption May Modify Antiglycan Antibodies and Fecal Fungal Composition in Patients With Ileo-Anal Pouch. 38
30535148 2019
43
The Effect of Smoking on the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-anal Anastomosis. 38
30124837 2019
44
Response to the Letter to the Editor from Dai et al, Regarding "Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients with Ileal Pouch Anal Anastomosis". 38
30124832 2019
45
Comparable perioperative outcomes, long-term outcomes, and quality of life in a retrospective analysis of ulcerative colitis patients following 2-stage versus 3-stage proctocolectomy with ileal pouch-anal anastomosis. 38
30610435 2019
46
Factors Associated with Long-Term Quality of Life After Restorative Proctocolectomy with Ileal Pouch Anal Anastomosis. 38
30097964 2019
47
Ustekinumab Is Effective for the Treatment of Crohn's Disease of the Pouch in a Multicenter Cohort. 38
30295784 2019
48
Fruit consumption is associated with alterations in microbial composition and lower rates of pouchitis. 38
30828722 2019
49
Short-term Results After Totally Robotic Restorative Total Proctocolectomy With Ileal Pouch Anal Anastomosis for Ulcerative Colitis. 38
30768495 2019
50
Clinical Outcomes After Ileal Pouch-Anal Anastomosis in Pediatric Patients. 38
30527503 2019
51
Inflammation and Neoplasia of the Pouch in Inflammatory Bowel Disease. 38
30815755 2019
52
A Comprehensive Approach to Pouch Disorders. 38
30124882 2019
53
Adalimumab in the treatment of chronic pouchitis. A randomized double-blind, placebo-controlled trial. 38
30739519 2019
54
Pouchitis as an Indication for Ileal Pouch Surgical Revision. 38
29939252 2019
55
Infliximab in inflammatory bowel disease. 38
30937157 2019
56
Insights into the role of fecal microbiota transplantation for the treatment of inflammatory bowel disease. 38
30906424 2019
57
Oligonucleotides-A Novel Promising Therapeutic Option for IBD. 38
31068803 2019
58
The therapy of chronic pouchitis. 38
30623632 2019
59
The Epithelial Barrier Model Shows That the Properties of VSL#3 Depend from Where it is Manufactured. 38
30360752 2019
60
Festschrift for Ronan O'Connell: pouchitis, ulcerative colitis and the microbiome. 38
29524104 2018
61
Anxiety, depression, and inflammation after restorative proctocolectomy. 38
29959529 2018
62
Refractory Chronic Pouchitis and Autoimmune Hemolytic Anemia Successfully Treated with Vedolizumab. 38
30480056 2018
63
Long-term outcomes following restorative proctocolectomy ileal pouch-anal anastomosis in pediatric ulcerative colitis patients: Multicenter national study in Japan. 38
30460346 2018
64
Outcomes following two-stage surgical approaches in the treatment of pediatric ulcerative colitis. 38
30414691 2018
65
Early first episode of pouchitis after ileal pouch-anal anastomosis for pediatric ulcerative colitis is a risk factor for development of chronic pouchitis. 38
30446392 2018
66
Long-term functional outcome after restorative proctocolectomy: a cross-sectional study. 38
30346218 2018
67
Placebo Rates in Randomized Controlled Trials of Pouchitis Therapy. 38
29995184 2018
68
Data on changes to mucosal inflammation and the intestinal microbiota following dietary micronutrients in genetically susceptible hosts. 38
30175203 2018
69
Successful treatment with tacrolimus of refractory pyoderma gangrenosum with pouchitis after restorative proctocolectomy for ulcerative colitis. 38
30618342 2018
70
From bench to bedside: Fecal calprotectin in inflammatory bowel diseases clinical setting. 38
30197475 2018
71
Long term outcomes of initial infliximab therapy for inflammatory pouch pathology: a multi-Centre retrospective study. 38
30270685 2018
72
Outcomes and Management of the Ileal Pouch-Anal Anastomosis in the Elderly. 38
29998454 2018
73
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care-An Evidence-based Guideline From European Crohn's and Colitis Organization and European Society of Paediatric Gastroenterology, Hepatology and Nutrition. 38
30044357 2018
74
A systematic review and meta-analysis comparing adverse events and functional outcomes of different pouch designs after restorative proctocolectomy. 38
29577558 2018
75
Targeting Endothelial Ligands: ICAM-1/alicaforsen, MAdCAM-1. 38
29757363 2018
76
Probiotics in Gastroenterology: How Pro Is the Evidence in Adults? 38
29915396 2018
77
Reliability among central readers in the evaluation of endoscopic disease activity in pouchitis. 38
29660321 2018
78
Vedolizumab in the treatment of Crohn's disease of the pouch. 38
30151202 2018
79
Laparoscopic vs open restorative proctocolectomy with IPAA for ulcerative colitis: Impact of surgical technique on creating a well functioning pouch. 38
29649668 2018
80
J Pouch: Imaging Findings, Surgical Variations, Natural History, and Common Complications. 38
29787362 2018
81
Ustekinumab Rescue Therapy in a Patient With Chronic Refractory Pouchitis. 38
29659775 2018
82
Pouch Volvulus in Patients Having Undergone Restorative Proctocolectomy for Ulcerative Colitis: A Case Series. 38
29664798 2018
83
Biologics and immunomodulators for treating Crohn's disease developing after surgery for an initial diagnosis of ulcerative colitis: a review of current literature. 38
29719998 2018
84
Smoking and the Risk of Pouchitis in Ulcerative Colitis Patients With Ileal Pouch-Anal Anastomosis. 38
29788269 2018
85
Management of Paediatric Ulcerative Colitis, Part 1: Ambulatory Care- an Evidence-Based Guideline from ECCO and ESPGHAN. 38
29851766 2018
86
Use of vedolizumab in a patient with chronic and refractory pouchitis. 38
29720865 2018
87
MRI defecography of the ileal pouch-anal anastomosis-contributes little to the understanding of functional outcome. 38
29520456 2018
88
Value of routine stool testing for pathogenic bacteria in the evaluation of symptomatic patients with ileal pouches. 38
29780596 2018
89
Efficacy and Safety of Endoscopic Balloon Dilatation of Ileoanal Pouch Strictures. 38
29697797 2018
90
Modified Pfannenstiel Open Approach as an Alternative to Laparoscopic Total Proctocolectomy and IPAA: Comparison of Short- and Long-term Outcomes and Quality of Life. 38
29630002 2018
91
Dietary antioxidant micronutrients alter mucosal inflammatory risk in a murine model of genetic and microbial susceptibility. 38
29331497 2018
92
Diversion colitis and pouchitis: A mini-review. 38
29713128 2018
93
Dyssynergic Defecation in Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis. 38
29529194 2018
94
Management of Pouchitis and Other Common Complications of the Pouch. 38
29688472 2018
95
Increase in Processing Factors Is Involved in Skewed MicroRNA Expression in Patients with Ulcerative Colitis Who Develop Small Intestine Inflammation after Pouch Surgery. 38
29688474 2018
96
Incidence and Long-term Implications of Prepouch Ileitis: An Observational Study. 38
29369899 2018
97
Long-term follow-up of the use of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis. 38
29588846 2018
98
Effective use of ustekinumab for prepouch ileitis without improvement of concomitant pouchitis. 38
29423578 2018
99
Laparoscopic-assisted Duhamel procedure with ex-anal rectal transection for total colonic aganglionosis. 38
28705638 2018
100
Long-term outcomes following ileal pouch-anal anastomosis in patients with indeterminate colitis. 38
29325789 2018
101
Another RESIN for Pouchitis: Chronic Pouchitis With Erosion Secondary to Sodium Polystyrene Sulfonate Crystals. 38
29535436 2018
102
Editorial: biologic therapy for chronic pouchitis - are we beginning to meet the unmet need? 38
29446134 2018
103
Vedolizumab in the treatment of chronic, antibiotic-dependent or refractory pouchitis. 38
29266360 2018
104
Peripouch Fat Area Measured on MRI Image and Its Association With Adverse Pouch Outcomes. 38
29506071 2018
105
Clinical Implication of Enlarged Prostate in Patients with the Ileal Pouch-anal Anastomosis for Inflammatory Bowel Disease. 38
29511399 2018
106
Ileal pouch of ulcerative colitis and familial adenomatous polyposis patients exhibit modulation of autophagy markers. 38
29422639 2018
107
Primary fecal diversion and bowel dysfunction in restorative proctocolectomy for ulcerative colitis: a nationwide cross-sectional study. 38
29302751 2018
108
Systematic review: ileoanal pouch microbiota in health and disease. 38
29205422 2018
109
Early Outcome of Patient with Ulcerative Colitis who Received High Dose of Steroid and Underwent Two Staged Total Proctocolectomy. 38
29456982 2018
110
Colonic Histological Criteria Predict Development of Pouchitis after Ileal Pouch: Anal Anastomosis for Patients with Ulcerative Colitis. 38
28662525 2018
111
Biological therapy for the treatment of prepouch ileitis: a retrospective observational study from three centers. 38
30588057 2018
112
Systematic Review With Meta-Analysis: Anti-TNF Therapy in Refractory Pouchitis and Crohn's Disease-Like Complications of the Pouch After Ileal Pouch-Anal Anastomosis Following Colectomy for Ulcerative Colitis. 38
29361101 2018
113
[Recalcitrant pouchitis treated by budesonide foam:a case report]. 38
30416152 2018
114
Neoterminal Ileal Polyposis and Ulceration after Restorative Proctocolectomy with a Current Review of the Literature. 38
29805360 2018
115
Routine Pouchoscopy Prior to Ileostomy Takedown May Not Be Necessary in Patients with Chronic Ulcerative Colitis. 38
28595172 2018
116
Refractory pouchitis improves after administration of the green tea polyphenol EGCG: a retrospective review. 38
28929216 2018
117
Determinants of optimal bowel function in ileal pouch-anal anastomosis - physiological differences contributing to pouch function. 38
29043868 2018
118
Altered expression of microRNAs in patients with pouchitis after restorative proctocolectomy. 38
28600635 2017
119
Complications in children with ulcerative colitis undergoing ileal pouch-anal anastomosis. 38
29126508 2017
120
Probiotics in Inflammatory Bowel Disease. 38
29173520 2017
121
Obese Patients Undergoing Ileal Pouch-Anal Anastomosis: Short-and Long-term Surgical Outcomes. 38
28922254 2017
122
Successful Treatment With Vedolizumab in a Patient With Chronic Refractory Pouchitis and Primary Sclerosing Cholangitis. 38
29106505 2017
123
Outcome after restorative proctocolectomy and ileal pouch-anal anastomosis in children and adults. 38
28940230 2017
124
Hyperbaric oxygen therapy for chronic antibiotic-refractory ischemic pouchitis. 38
26319238 2017
125
Alicaforsen in the treatment of pouchitis. 38
29067882 2017
126
NOD2 Genetic Variants Predispose One of Two Familial Adenomatous Polyposis Siblings to Pouchitis Through Microbiome Dysbiosis. 38
28633443 2017
127
Abdominal Visceral Fat Area and Chronic Pouchitis after Ileal Pouch-Anal Anastomosis. 38
29391089 2017
128
Transanal Assisted Resection with Closure of Anal Canal for Lower Rectal Diseases. 38
28982899 2017
129
Faecal Microbiota Transplantation for Inflammatory Bowel Disease: A Systematic Review and Meta-analysis. 38
28486648 2017
130
Successful treatment of chronic refractory pouchitis with vedolizumab. 38
28698974 2017
131
The prevalence of chronic peri-pouch sepsis in patients treated for antibiotic-dependent or refractory primary idiopathic pouchitis. 38
27688067 2017
132
Laparoscopic Duhamel Procedure with Ex-Anal Rectal Transection for Right-Sided Hirschsprung's Disease. 38
28737964 2017
133
Predictors of pouchitis after ileal pouch-anal anastomosis in pediatric-onset ulcerative colitis. 38
28542114 2017
134
The outcome of ulcerative colitis patients undergoing pouch surgery is determined by pre-surgical factors. 38
28664992 2017
135
Successful Treatment With Ustekinumab for Chronic Refractory Pouchitis. 38
28199485 2017
136
Fecal microbiota transplantation for Clostridium difficile infection in patients with ileal pouches. 38
28852524 2017
137
Alicaforsen for the treatment of inflammatory bowel disease. 38
28670932 2017
138
Nonrelaxing Pelvic Floor Dysfunction Is an Underestimated Complication of Ileal Pouch-Anal Anastomosis. 38
28259741 2017
139
Efficacy and Factors Associated with Treatment Response of Intravenous Immunoglobulin in Inpatients with Refractory Inflammatory Bowel Diseases. 38
28452863 2017
140
Preoperative Clostridium difficile Infection Does Not Affect Pouch Outcomes in Patients with Ulcerative Colitis Who Undergo Ileal Pouch-anal Anastomosis. 38
28410344 2017
141
[Differential indications for ileoanal pouch anastomosis : Ulcerative colitis, familial adenomatous polyposis, synchronous colorectal cancer - Crohn's disease, constipation]. 38
28405717 2017
142
[Surgical strategy to save ileoanal pouch reconstruction]. 38
28573532 2017
143
Lactobacillus acidophilus alleviates pouchitis after ileal pouch-anal anastomosis in rats. 38
28765694 2017
144
Cryptosporidium Pouchitis. 38
28223201 2017
145
Preoperative Extraintestinal Manifestations Associated with Chronic Pouchitis in Japanese Patients with Ulcerative Colitis After Ileal Pouch-anal Anastomosis: A Retrospective Study. 38
28346273 2017
146
Review of the role of probiotics in gastrointestinal diseases in adults. 38
28185664 2017
147
Intestinal Barrier Disruption in Ileal Pouchitis After Ileal Pouch-Anal Anastomosis in a Rat Model. 38
28486255 2017
148
Inflammatory bowel disease in liver transplanted patients. 38
28566881 2017
149
Laparoscopic Conversion of One Anastomosis Gastric Bypass to a Standard Roux-en-Y Gastric Bypass. 38
28303507 2017
150
Central Serous Chorioretinopathy in a Patient with Ulcerative Colitis with Pouchitis on Budesonide-EC. 38
28328626 2017
151
Results at Up to 30 Years After Ileal Pouch-Anal Anastomosis for Chronic Ulcerative Colitis. 38
28301429 2017
152
Long-term Outcomes After Continent Ileostomy Creation in Patients With Crohn's Disease. 38
28383450 2017
153
Sulfasalazine in Prevention of Pouchitis After Proctocolectomy with Ileal Pouch-Anal Anastomosis for Ulcerative Colitis. 38
28110377 2017
154
Successful treatment of pouchitis with Vedolizumab, but not fecal microbiota transfer (FMT), after proctocolectomy in ulcerative colitis. 38
28097380 2017
155
The Mexican consensus on probiotics in gastroenterology. 38
28104319 2017
156
Frequency and Risk Factors of Clostridium difficile Infection in Hospitalized Patients With Pouchitis: A Population-based Study. 38
28296825 2017
157
Early Transcriptomic Changes in the Ileal Pouch Provide Insight into the Molecular Pathogenesis of Pouchitis and Ulcerative Colitis. 38
28221248 2017
158
Surgical treatment for ulcerative colitis. 38
30566787 2017
159
Outcome and functional prognosis of pelvic sepsis after ileal pouch-anal anastomosis in patients with ulcerative colitis. 38
27822614 2017
160
Systematic review with meta-analysis: the management of chronic refractory pouchitis with an evidence-based treatment algorithm. 38
28008631 2017
161
Alterations of Enteric Microbiota in Patients with a Normal Ileal Pouch Are Predictive of Pouchitis. 38
27613294 2017
162
Efficacy of granulocyte and monocyte apheresis for antibiotic-refractory pouchitis after proctocolectomy for ulcerative colitis: an open-label, prospective, multicentre study. 38
28203278 2017
163
Roles for Intestinal Bacteria, Viruses, and Fungi in Pathogenesis of Inflammatory Bowel Diseases and Therapeutic Approaches. 38
27769810 2017
164
The Emerging Therapeutic Role of Medical Foods for Gastrointestinal Disorders. 38
28450817 2017
165
Tripterygium wilfordii polyglycosidium ameliorates pouchitis induced by dextran sulfate sodium in rats. 38
27988458 2017
166
Pouchitis after ileal pouch-anal anastomosis in ulcerative colitis: Diagnosis, management, risk factors, and incidence. 38
27681447 2017
167
Factors affecting pouch-related outcomes after restorative proctocolectomy. 38
29049337 2017
168
Combination therapy with vedolizumab and etanercept in a patient with pouchitis and spondylarthritis. 38
28243458 2017
169
Endoscopic Treatment of Bleeding Diversion Pouchitis with High-Concentration Dextrose Spray. 38
28377939 2017
170
Adaptive Returns of Deficient Systemic Plasma Immunoglobulin G Levels as Rehabilitation Biomarker After Emergency Colectomy for Fulminant Ulcerative Colitis. 38
29276421 2017
171
Probiotics in Curing Allergic and Inflammatory Conditions - Research Progress and Futuristic Vision. 38
28029082 2017
172
Efficacy of Vedolizumab in Patients with Antibiotic and Anti-tumor Necrosis Alpha Refractory Pouchitis. 38
27930413 2017
173
Specific members of the predominant gut microbiota predict pouchitis following colectomy and IPAA in UC. 38
26423113 2017
174
Metabolic Variability of a Multispecies Probiotic Preparation Impacts on the Anti-inflammatory Activity. 38
28804459 2017
175
Ileal pouch-anal anastomosis 20 years later: is it still a good surgical option for patients with ulcerative colitis? 38
27682647 2016
176
Pouchitis in Pediatric Ulcerative Colitis Patients After Ileal Pouch Anal Anastomosis. 38
27602702 2016
177
[Proctocolectomy with J pouch. Ileo-anal anastomosis performed with PPH stapler. Our experiences after 88 cases]. 38
27991017 2016
178
Role of prebiotics and probiotics in pediatric diseases. 38
25926157 2016
179
Management of pouch dysfunction in a tertiary centre. 38
27088646 2016
180
The role of dietary supplements in inflammatory bowel disease: a systematic review. 38
27769076 2016
181
Can probiotics benefit children with autism spectrum disorders? 38
28028357 2016
182
Predictors of Pouchitis After Ileal Pouch-Anal Anastomosis in Children. 38
27574882 2016
183
An update on probiotics, prebiotics and symbiotics in clinical nutrition. 38
27633133 2016
184
Probiotics and Liver Disease: Where Are We Now and Where Are We Going? 38
27741172 2016
185
Patient-Specific Bacteroides Genome Variants in Pouchitis. 38
27935837 2016
186
Fecal microbiota in pouchitis and ulcerative colitis. 38
27833384 2016
187
Review article: the pathogenesis of pouchitis. 38
27554912 2016
188
Predictors of Pouchitis After Ileal Pouch-Anal Anastomosis in Children. 38
27243421 2016
189
Systematic review: outcomes and post-operative complications following colectomy for ulcerative colitis. 38
27534519 2016
190
Pouchitis Is a Common Complication in Patients With Familial Adenomatous Polyposis Following Ileal Pouch-Anal Anastomosis. 38
27085760 2016
191
Postoperative excessive gain in visceral adipose tissue as well as body mass index are associated with adverse outcomes of an ileal pouch. 38
27666926 2016
192
Management of Inflammatory Bowel Disease in the Elderly. 38
27387455 2016
193
Effect of probiotics (Lactobacillus plantarum 299 plus Bifidobacterium Cure21) in patients with poor ileal pouch function: a randomised controlled trial. 38
27150635 2016
194
Ursodeoxycholic Acid Inhibits Clostridium difficile Spore Germination and Vegetative Growth, and Prevents the Recurrence of Ileal Pouchitis Associated With the Infection. 38
26485102 2016
195
Pouchitis Associated With Pelvic Radiation for Prostate Cancer. 38
27807581 2016
196
Intraepithelial lymphocytosis is a frequent finding in biopsies from ileal pouch-anal anastomoses. 38
27063473 2016
197
Surgical outcomes, bowel habits and quality of life in young patients after ileoanal anastomosis for ulcerative colitis. 38
27417342 2016
198
Ileal Pouch Biopsy Triggers Investigation and Diagnosis of Systemic Mastocytosis. 38
27807556 2016
199
The effect of Clostridium butyricum MIYAIRI on the prevention of pouchitis and alteration of the microbiota profile in patients with ulcerative colitis. 38
26510664 2016
200
Modulation of microbiota as treatment for intestinal inflammatory disorders: An uptodate. 38
27621567 2016
201
Role of intestinal flora imbalance in pathogenesis of pouchitis. 38
27569889 2016
202
Long-term follow up of ileal pouch anal anastomosis in a large cohort of pediatric and young adult patients with ulcerative colitis. 38
26876089 2016
203
Secondary pouchitis in a pediatric patient successfully treated by salvage surgery. 38
27097567 2016
204
Systematic review with meta-analysis: the effect of tobacco smoking on the natural history of ulcerative colitis. 38
27193202 2016
205
Early and late surgical outcomes of ileal pouch-anal anastomosis within a defined population in Sweden. 38
26945126 2016
206
Immunoglobulin G4 (IgG4)-associated pouchitis - Part of IgG4 related disease? A case series and review of the literature. 38
27038705 2016
207
French national consensus clinical guidelines for the management of ulcerative colitis. 38
27158125 2016
208
Common Inflammatory Disorders and Neoplasia of the Ileal Pouch: A Review of Histopathology. 38
27785322 2016
209
Insights into the pathogenesis of ulcerative colitis from a murine model of stasis-induced dysbiosis, colonic metaplasia, and genetic susceptibility. 38
27079612 2016
210
Restorative Proctocolectomy for Ulcerative Colitis in 1985-2009. 38
26063652 2016
211
Crohn's Disease of the Ileoanal Pouch. 38
27057684 2016
212
Ileal J-Pouch Volvulus Following Total Proctocolectomy for Ulcerative Colitis. 38
26643297 2016
213
Clostridium difficile infection after restorative proctocolectomy and ileal pouch anal anastomosis for ulcerative colitis. 38
26945555 2016
214
Successful treatment of chronic Pouchitis utilizing fecal microbiota transplantation (FMT): a case report. 38
26525055 2016
215
Infliximab to Treat Refractory Inflammation After Pelvic Pouch Surgery for Ulcerative Colitis. 38
26721938 2016
216
Endoluminal calprotectin measurement in assessment of pouchitis and a new index of disease activity: a pilot study. 38
26901424 2016
217
Long-term outcomes and sex differences after restorative proctocolectomy in pediatric patients with ulcerative colitis. 38
26561247 2016
218
Laparoscopic Conversion of One Anastomosis Gastric Bypass to Roux-en-Y Gastric Bypass for Chronic Bile Reflux. 38
26746224 2016
219
Incidence and Severity of Prepouch Ileitis: A Distinct Disease Entity or a Manifestation of Refractory Pouchitis? 38
26383915 2016
220
Nonbloody Diarrhea but Not Significant Weight Loss at Diagnosis Is Associated with the Development of Denovo Crohn's Disease After Ileal Pouch-anal Anastomosis for Ulcerative Colitis. 38
26595552 2016
221
Relevance of fecal calprotectin and lactoferrin in the post-operative management of inflammatory bowel diseases. 38
27022446 2016
222
Male Gender Is Associated with a High Risk for Chronic Antibiotic-Refractory Pouchitis and Ileal Pouch Anastomotic Sinus. 38
26446071 2016
223
Short article: Successful faecal coliform sensitivity-based oral ertapenem therapy for chronic antibiotic-refractory pouchitis: a case series. 38
26657456 2016
224
Fecal Microbiota Transfer in Patients With Chronic Antibiotic-Refractory Pouchitis. 38
27018122 2016
225
Clinical Uses of Probiotics. 38
26844491 2016
226
Diet therapy for inflammatory bowel diseases: The established and the new. 38
26900283 2016
227
Surgical aspects of inflammatory bowel diseases in pediatric and adolescent age groups. 38
26410260 2016
228
Auto-inflammatory diseases in ileal pouch patients with NOD2/CARD15 mutations. 38
25313006 2016
229
The current place of probiotics and prebiotics in the treatment of pouchitis. 38
27048898 2016
230
Probiotics and prebiotics in Crohn's disease therapies. 38
27048899 2016
231
Alicaforsen, an antisense inhibitor of ICAM-1, as treatment for chronic refractory pouchitis after proctocolectomy: A case series. 38
26966529 2016
232
Role of antibiotics for treatment of inflammatory bowel disease. 38
26811648 2016
233
Comparison of three commercial fecal calprotectin ELISA test kits used in patients with Inflammatory Bowel Disease. 38
26359672 2016
234
Methodological Quality Assessment of Meta-Analyses and Systematic Reviews of Probiotics in Inflammatory Bowel Disease and Pouchitis. 38
28005973 2016
235
MicroRNAs Expression in the Ileal Pouch of Patients with Ulcerative Colitis Is Robustly Up-Regulated and Correlates with Disease Phenotypes. 38
27536783 2016
236
Any Future for Fecal Microbiota Transplantation as Treatment Strategy for Inflammatory Bowel Diseases? 38
27548724 2016
237
Production Conditions Affect the In Vitro Anti-Tumoral Effects of a High Concentration Multi-Strain Probiotic Preparation. 38
27657913 2016
238
Problems after restorative proctocolectomy: assessment and therapy. 38
26628102 2016
239
Campylobacter Pouchitis Mimicking the Appearance of Crohn's Disease. 38
27555972 2016
240
[Application of ileal D-pouch anal anastomosis in the treatment of ulcerative colitis and familial adenomatous polyposis]. 38
26704005 2015
241
Bugs and Guts: Practical Applications of Probiotics for Gastrointestinal Disorders in Children. 38
26538058 2015
242
Psychological Factors in Irritable Pouch Syndrome and Other Pouch Disorders. 38
26398708 2015
243
Role of Probiotics in Crohn's Disease and in Pouchitis. 38
26447964 2015
244
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. 38
26593456 2015
245
Long-term outcomes of ileal pouch-anal anastomosis for pediatric chronic ulcerative colitis. 38
25863545 2015
246
Serology of Patients with Ulcerative Colitis After Pouch Surgery Is More Comparable with that of Patients with Crohn's Disease. 38
26197448 2015
247
Scintigraphic Small Intestinal Transit Time and Defaecography in Patients with J-Pouch. 38
26854162 2015
248
Safety and efficacy of iodine-125 permanent prostate brachytherapy in patients with J-pouch anastomosis after total colectomy for ulcerative colitis. 38
25899222 2015
249
Pouch Inflammation Is Associated With a Decrease in Specific Bacterial Taxa. 38
26026389 2015
250
Large bowel mucosal neoplasia in the original specimen may increase the risk of ileal pouch neoplasia in patients following restorative proctocolectomy for ulcerative colitis. 38
26022647 2015
251
Quality of life, continence and frequency of pouchitis following laparoscopic versus open colectomy and ileal pouch-anal anastomosis: an Irish perspective. 38
25422064 2015
252
Use of Biologics in Pouchitis: A Systematic Review. 38
26084005 2015
253
Inflammatory pouch disease: The spectrum of pouchitis. 38
26269664 2015
254
Variable alterations of the microbiota, without metabolic or immunological change, following faecal microbiota transplantation in patients with chronic pouchitis. 38
26264409 2015
255
Surgical Principles in the Treatment of Ulcerative Colitis. 38
26557832 2015
256
Systematic review: the financial burden of surgical complications in patients with ulcerative colitis. 38
25855078 2015
257
FK506-Binding Protein 5 mRNA Levels in Ileal Mucosa Are Associated with Pouchitis in Patients with Ulcerative Colitis. 38
25596721 2015
258
Serial Fecal Calprotectin and Lactoferrin Measurements for Early Diagnosis of Pouchitis After Proctocolectomy for Ulcerative Colitis: Is Pouchoscopy No Longer Needed? 38
26052770 2015
259
Consecutive Monitoring of Fecal Calprotectin and Lactoferrin for the Early Diagnosis and Prediction of Pouchitis after Restorative Proctocolectomy for Ulcerative Colitis. 38
25916224 2015
260
Gene expression alterations in ulcerative colitis patients after restorative proctocolectomy extend to the small bowel proximal to the pouch. 38
24982202 2015
261
IPAA-related sepsis significantly increases morbidity of ileoanal pouch excision. 38
25850835 2015
262
Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review. 38
25954111 2015
263
Ileal J-Pouch Perforation: Case Report. 38
26158741 2015
264
Associations between host gene expression, the mucosal microbiome, and clinical outcome in the pelvic pouch of patients with inflammatory bowel disease. 38
25887922 2015
265
Systematic review with meta-analysis: the efficacy of a second anti-TNF in patients with inflammatory bowel disease whose previous anti-TNF treatment has failed. 38
25652884 2015
266
[Surgery for ulcerative colitis]. 38
26050511 2015
267
Male issues of the ileal pouch. 38
25437820 2015
268
The diagnostic value of a new fecal marker, matrix metalloprotease-9, in different types of inflammatory bowel diseases. 38
25585596 2015
269
Is it really small-bowel obstruction in patients with paradox after IPAA? 38
25664711 2015
270
Ileal pouch morphology and microbiology in ulcerative colitis patients. 38
25931359 2015
271
Serum alpha-1 antitrypsin: a noninvasive marker of pouchitis. 38
25659085 2015
272
Faecal metabolite profiling identifies medium-chain fatty acids as discriminating compounds in IBD. 38
24811995 2015
273
Faecal matrix metalloprotease-9 is a more sensitive marker for diagnosing pouchitis than faecal calprotectin: results from a pilot study. 38
25264031 2015
274
Laparoscopic IPAA is not associated with decreased rates of incisional hernia and small-bowel obstruction when compared with open technique: long-term follow-up of a case-matched study. 38
25664709 2015
275
Systematic review: new serological markers (anti-glycan, anti-GP2, anti-GM-CSF Ab) in the prediction of IBD patient outcomes. 38
25462578 2015
276
Ulcerative ileitis after proctocolectomy in children: a complication of ulcerative colitis or a disease in itself after ileoanal pullthrough? 38
25144351 2015
277
[Uses in gastroenterology]. 38
25659050 2015
278
Distinctive inflammatory bowel disease phenotype in primary sclerosing cholangitis. 38
25684965 2015
279
Autoimmune features are associated with chronic antibiotic-refractory pouchitis. 38
25437817 2015
280
Transcriptional changes between uninflamed ulcerative colitis and familial adenomatous polyposis pouch mucosa can be attributed to an altered immune response. 38
25654358 2015
281
Frequency, Clinical Features and Factors Associated with Pouchitis after Proctocolectomy with Ileo-Pouch-Anal Anastomosis in Patients with Ulcerative Colitis: A Latin-American Country Retrospective-Cohort Study. 38
26609703 2015
282
The role of probiotic lactic acid bacteria and bifidobacteria in the prevention and treatment of inflammatory bowel disease and other related diseases: a systematic review of randomized human clinical trials. 38
25793197 2015
283
Prebiotics and probiotics in irritable bowel syndrome and inflammatory bowel disease in children. 38
25391345 2015
284
Role of Rifaximin in Inflammatory Bowel Disease Treatment. 38
26202194 2015
285
The therapeutic potential of antibiotics and probiotics in the treatment of pouchitis. 38
26202437 2015
286
Clinical Features of Refractory Pouchitis with Penetrating Lesions and the Efficacy of Infliximab Treatment for Patients with Ulcerative Colitis after Restorative Proctocolectomy. 38
26343749 2015
287
Review of our ileal pouch experience in the light of literature. 38
25931950 2015
288
Towards anatomic scale agent-based modeling with a massively parallel spatially explicit general-purpose model of enteric tissue (SEGMEnT_HPC). 38
25806784 2015
289
Update on the pathogenesis and management of pouchitis. 38
25348740 2014
290
Risk factors and management of refractory or recurrent clostridium difficile infection in ileal pouch patients. 38
25222656 2014
291
Clostridium difficile infection in the postcolectomy patient. 38
25401722 2014
292
Probiotics to counteract biofilm-associated infections: promising and conflicting data. 38
25257882 2014
293
Chronic antibiotic-refractory diversion pouchitis successfully treated with leukocyteapheresis. 38
24571541 2014
294
Management of ulcerative colitis pre- and post-liver transplant for primary sclerosing cholangitis: two case reports and review of literature. 38
24990353 2014
295
Modulating the microbiota in inflammatory bowel diseases: prebiotics, probiotics or faecal transplantation? 38
24969143 2014
296
Innate immune factors in the development and maintenance of pouchitis. 38
25222658 2014
297
Comparison of long-term outcomes of S and J pouches and continent ileostomies in ulcerative colitis patients with restorative proctocolectomy-experience in subspecialty pouch center. 38
24657364 2014
298
An uncommon complication of chronic antibiotics refractory pouchitis after ileal pouch-anal anastomosis for ulcerative colitis. 38
25158030 2014
299
Treatment strategy for preventing pouchitis as a postoperative complication of ulcerative colitis: the significance of the management of cuffitis. 38
25022954 2014
300
Pouchitis: prevention and treatment. 38
25023187 2014
301
Ileal j pouch complications and surgical solutions: a review. 38
24983986 2014
302
Intestinal microbiota, probiotics and prebiotics in inflammatory bowel disease. 38
25206258 2014
303
Colonic phenotype of the ileum in Crohn's disease: a prospective study before and after ileocolonic resection. 38
25054336 2014
304
Cyclosporine in steroid refractory acute severe colitis. 38
25735123 2014
305
Association between gastro-intestinal symptoms and menstruation in patients with ileal pouches. 38
25016379 2014
306
Relationship between pouch microbiota and pouchitis following restorative proctocolectomy for ulcerative colitis. 38
25110406 2014
307
Practical approaches to probiotics use. 38
24797031 2014
308
Role of intestinal bacteria in the pathogenesis of pouchitis. 38
25046009 2014
309
The extent of inflammation is a predictor for pouch-related complications in ileal pouches in patients with ulcerative or indeterminate colitis. 38
24635999 2014
310
Cytomegalovirus pouchitis in a patient with Crohn's disease. 38
25035450 2014
311
Ileorectal anastomosis in comparison with ileal pouch anal anastomosis in reconstructive surgery for ulcerative colitis--a single institution experience. 38
24315777 2014
312
Outcomes after ileal pouch anal anastomosis in patients with primary sclerosing cholangitis. 38
24418660 2014
313
Downregulation of expression of xenobiotic efflux genes is associated with pelvic pouch inflammation in ulcerative colitis. 38
24874456 2014
314
Clostridium difficile infection in patients with ileal pouches. 38
24989088 2014
315
Gut microbiota and inflammatory bowel disease: the role of antibiotics in disease management. 38
25141239 2014
316
Oral beclomethasone dipropionate in chronic refractory pouchitis. 38
24394806 2014
317
Complications after ileal pouch-anal anastomosis in Korean patients with ulcerative colitis. 38
24966620 2014
318
Raised tacrolimus level and acute renal injury associated with acute gastroenteritis in a child receiving local rectal tacrolimus. 38
26183743 2014
319
The TNFSF15 gene single nucleotide polymorphism rs7848647 is associated with surgical diverticulitis. 38
24814505 2014
320
Preoperative Clostridium difficile infection is not associated with an increased risk for the infection in ileal pouch patients. 38
24504594 2014
321
Protracted primary cytomegalovirus infection presenting as ileoanal pouchitis in a non-immunosuppressed patient: a case report. 38
24885004 2014
322
Chronic pouchitis is associated with pouch polyp formation in patients with underlying ulcerative colitis. 38
24169020 2014
323
Quality of life after proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitis. 38
24370856 2014
324
New serological markers in pediatric patients with inflammatory bowel disease. 38
24803798 2014
325
Colectomy for patients with ulcerative colitis and primary sclerosing cholangitis - what next? 38
24239402 2014
326
Ileal pouch symptoms do not correlate with inflammation of the pouch. 38
24075890 2014
327
Restorative proctocolectomy with J-pouch ileoanal anastomosis for total colonic aganglionosis among neonates and infants. 38
24726115 2014
328
Restoring the gut microbiome for the treatment of inflammatory bowel diseases. 38
24707129 2014
329
Alicaforsen: An Emerging Therapeutic Agent for Ulcerative Colitis and Refractory Pouchitis. 38
27785270 2014
330
Synchronous cytomegalovirus and Clostridium difficile infection of the pouch: a trigger for chronic pouchitis? 38
26183628 2014
331
Fiber in the treatment and maintenance of inflammatory bowel disease: a systematic review of randomized controlled trials. 38
24445775 2014
332
Role of capsule endoscopy in inflammatory bowel disease. 38
24574792 2014
333
The association between autoimmunity and pouchitis. 38
24374879 2014
334
Fecal transplantation therapy for Clostridium difficile-associated pouchitis. 38
24132529 2014
335
The intestinal microbiota in inflammatory bowel diseases. 38
25227293 2014
336
Systematic review of randomized controlled trials of probiotics, prebiotics, and synbiotics in inflammatory bowel disease. 38
25525379 2014
337
Probiotics in the management of Crohn's disease and ulcerative colitis. 38
24180407 2014
338
Effect of probiotics on inducing remission and maintaining therapy in ulcerative colitis, Crohn's disease, and pouchitis: meta-analysis of randomized controlled trials. 38
24280877 2014
339
Role of probiotics in the management of pouchitis. 38
24180410 2014
340
Managing intractable proctitis and the problematic pouch. 38
24969291 2014
341
One year of infliximab therapy successfully improved a case of refractory pouchitis without the use of antibiotics. 38
25400178 2014
342
Clinical outcome of ileal pouch-anal anastomosis for chronic ulcerative colitis in China. 38
24762596 2014
343
Serologic markers associated with development of Crohn's disease after ileal pouch anal anastomosis for ulcerative colitis. 38
24091907 2014
344
Long-term use of probiotics Lactobacillus and Bifidobacterium has a prophylactic effect on the occurrence and severity of pouchitis: a randomized prospective study. 38
24579075 2014
345
Antibiotics, probiotics and prebiotics in IBD. 38
25227297 2014
346
Probiotics and antibiotics in IBD. 38
25531348 2014
347
Functional outcomes and quality of life after restorative proctocolectomy in paediatric patients: a case-control study. 38
24744776 2014
348
The natural history of anal transition zone inflammation and possible relationship to pouchitis: a long-term longitudinal study. 38
23777389 2013
349
Pouchitis: what every gastroenterologist needs to know. 38
23602818 2013
350
Commentary: The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. 38
24206372 2013
351
Commentary: The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis - Authors' reply. 38
24206373 2013
352
Antibodies against glycoprotein 2 are novel markers of intestinal inflammation in patients with an ileal pouch. 38
23639628 2013
353
Clostridium difficile and inflammatory bowel disease: role in pathogenesis and implications in treatment. 38
24282348 2013
354
Clinical value of surveillance pouchoscopy in asymptomatic ileal pouch patients with underlying inflammatory bowel disease. 38
23877758 2013
355
Malignant melanoma of the ileo-anal pouch anastomosis after restorative proctocolectomy for ulcerative colitis: report of a case. 38
24188588 2013
356
Gene expression profiles of ileal inflammatory bowel disease correlate with disease phenotype and advance understanding of its immunopathogenesis. 38
24108111 2013
357
Preoperative pelvic radiation increases the risk for ileal pouch failure in patients with colitis-associated colorectal cancer. 38
23453430 2013
358
Oral ertapenem for refractory pouchitis. 38
23694856 2013
359
Long term benefit of one year infliximab administration for the treatment of chronic refractory pouchitis. 38
23523672 2013
360
Pathobiology and potential therapeutic value of intestinal short-chain fatty acids in gut inflammation and obesity. 38
23839339 2013
361
The effects of probiotics on barrier function and mucosal pouch microbiota during maintenance treatment for severe pouchitis in patients with ulcerative colitis. 38
23957603 2013
362
The NOD2insC polymorphism is associated with worse outcome following ileal pouch-anal anastomosis for ulcerative colitis. 38
22879519 2013
363
Cytomegalovirus infection of the ileoanal pouch: clinical characteristics and outcomes. 38
23974995 2013
364
Probiotics, prebiotics and symbiotics in inflammatory bowel diseases: state-of-the-art and new insights. 38
24382173 2013
365
Diet of patients after pouch surgery may affect pouch inflammation. 38
24151365 2013
366
Topical tacrolimus therapy for antibiotic-refractory pouchitis. 38
24022534 2013
367
Chronic pouchitis versus recurrent Crohn's disease: a diagnostic challenge. 38
23925821 2013
368
Is pyloric gland metaplasia in ileal pouch biopsies a marker for Crohn's disease? 38
23543088 2013
369
Inflammatory bowel disease after liver transplantation for primary sclerosing cholangitis. 38
23896954 2013
370
Infliximab for the treatment of pouchitis. 38
24303499 2013
371
Clinical features and management of pouchitis in Japanese ulcerative colitis patients. 38
23076686 2013
372
Low levels of vitamin D are common in patients with ileal pouches irrespective of pouch inflammation. 38
22967752 2013
373
Exclusive elemental diet impacts on the gastrointestinal microbiota and improves symptoms in patients with chronic pouchitis. 38
22857825 2013
374
Pouchitis: a practical guide. 38
28839726 2013
375
Risk factors for pouchitis after surgery for ulcerative colitis. 38
23570620 2013
376
Chronic use of PPI and H2 antagonists decreases the risk of pouchitis after IPAA for ulcerative colitis. 38
23532599 2013
377
Evaluation of long-term function, complications, quality of life and health status after restorative proctocolectomy with ileo neo rectal and with ileal pouch anal anastomosis for ulcerative colitis. 38
23406347 2013
378
Suppurative granulomatous inflammation in the ileo-anal pouch. 38
22824099 2013
379
The presence of primary sclerosing cholangitis is protective for ileal pouch from Crohn's disease. 38
23660996 2013
380
Fecal lactoferrin: a noninvasive fecal biomarker for the diagnosis and surveillance of pouchitis. 38
23652747 2013
381
Efficacy of biologic therapy in patients with chronic pouchitis. 38
22875487 2013
382
An update on the use and investigation of probiotics in health and disease. 38
23474420 2013
383
Outcome after ileal pouch-anal anastomosis for familial adenomatous polyposis compared to mucosal ulcerative colitis in a Middle Eastern population. 38
23793430 2013
384
Elemental diet therapy for pouchitis following restorative proctocolectomy for ulcerative colitis. 38
22981615 2013
385
Meta-analysis: serological markers and the risk of acute and chronic pouchitis. 38
23480145 2013
386
Correlation between serum serotonin and endoscopy inflammation scores in patients with ileal pouches. 38
22922006 2013
387
[The role of anti-TNF therapy in ulcerative colitis]. 38
24471300 2013
388
Ileal pouch anal anastomosis: analysis of outcome and quality of life in 3707 patients. 38
23299522 2013
389
[The role of biologic therapy in the treatment of extraintestinal manifestations and complications of inflammatory bowel disease]. 38
24471303 2013
390
Pouchitis associated with cytomegalovirus infection: a case study. 38
23314244 2013
391
Probiotics in the management of irritable bowel syndrome and inflammatory bowel disease. 38
23286925 2013
392
Chronic pouch inflammation and risk for new-onset extraintestinal cancers in patients with restorative proctocolectomy for ulcerative colitis. 38
23429461 2013
393
Self-reported assessment of health-related quality of life in children who underwent restorative proctocolectomy with ileal J-pouch anal anastomosis for ulcerative colitis. 38
23184266 2013
394
Multiphasic analysis of the temporal development of the distal gut microbiota in patients following ileal pouch anal anastomosis. 38
24451366 2013
395
Characteristics of extremely early-onset pouchitis after proctocolectomy with ileal pouch-anal anastomosis. 38
23254315 2013
396
Manometric evaluation of evacuatory difficulty (dyschezia) in ileal pouch patients. 38
23380934 2013
397
Ileal pouch anal anastomosis with modified double-stapled mucosectomy--the experience in China. 38
23483639 2013
398
Clinical course of cuffitis in ulcerative colitis patients with restorative proctocolectomy and ileal pouch-anal anastomoses. 38
23328773 2013
399
Risk factors and outcome of PCR-detected Clostridium difficile infection in ileal pouch patients. 38
23328770 2013
400
The gut microflora and its variety of roles in health and disease. 38
22476557 2013
401
Characterization of the gut-associated microbiome in inflammatory pouch complications following ileal pouch-anal anastomosis. 38
24086242 2013
402
Probiotics. 38
24246993 2013
403
[Ileo-anal pouch for inflammatory intestinal disease]. 38
24063669 2013
404
Oral bismuth for chronic intractable diarrheal conditions? 38
23515887 2013
405
Predictive factors for development of chronic pouchitis after ileal pouch-anal anastomosis in ulcerative colitis. 38
23949485 2013
406
Surgical outcome of ileal pouch-anal anastomosis when used intentionally for well-defined Crohn's disease. 38
22467562 2013
407
Evaluation of preoperative predictors of development of pouchitis after ileal-pouch-anastomosis in ulcerative colitis. 38
22705025 2012
408
Drivers of cost after surgical and medical therapy for chronic ulcerative colitis: a nested case-cohort study in Olmsted County, Minnesota. 38
23135584 2012
409
Adalimumab therapy in Crohn's disease of the ileal pouch. 38
22407820 2012
410
Randomized controlled trials in pouchitis. 38
23092236 2012
411
Probiotics for human health -new innovations and emerging trends. 38
23181893 2012
412
Utility of fecal and serum anti-Saccharomyces cerevisiae antibodies in the diagnosis of Crohn's disease-like condition of the pouch. 38
22430887 2012
413
Risk factors for chronic pouchitis after ileal pouch-anal anastomosis: a prospective cohort study. 38
22339717 2012
414
Quality of life in patients postcolectomy for pediatric-onset ulcerative colitis. 38
22437468 2012
415
Stricture of ileo-anal J pouch anastomosis increased the intensity of pouchitis in an experimental rat model. 38
23018348 2012
416
Outcome of total proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. 38
22977759 2012
417
Surgical treatment of familial adenomatous polyposis: experience from a single institution in China. 38
22897208 2012
418
Probiotics for the treatment of inflammatory bowel disease. 38
22581276 2012
419
Role of surgery in severe ulcerative colitis in the era of medical rescue therapy. 38
22876035 2012
420
Matrix metalloproteinases in the restorative proctocolectomy pouch of pediatric ulcerative colitis. 38
22912554 2012
421
Long-term functional outcome after restorative proctocolectomy in patients with ulcerative colitis. 38
22053822 2012
422
Histopathological evaluation and risk factors related to the development of pouchitis in patients with ileal pouches for ulcerative colitis. 38
22892912 2012
423
Detection of CMV in pouch mucosa in a patient with acute pouchitis: the real enemy or an innocent bystander? 38
22410348 2012
424
Efficacy of adalimumab rescue therapy in patients with chronic refractory pouchitis previously treated with infliximab: a case series. 38
22395225 2012
425
Drug transfer to the fetus and to the breastfeeding infant: what do we know? 38
22762278 2012
426
Etiology of pouchitis. 38
22021180 2012
427
Impact of budesonide on liver function tests and gut inflammation in patients with primary sclerosing cholangitis and ileal pouch anal anastomosis. 38
22398056 2012
428
Fecal markers: calprotectin and lactoferrin. 38
22500530 2012
429
ASCA IgG and CBir antibodies are associated with the development of Crohn's disease and fistulae following ileal pouch-anal anastomosis. 38
22311367 2012
430
Comprehensive analysis of the bacterial content of stool from patients with chronic pouchitis, normal pouches, or familial adenomatous polyposis pouches. 38
22114001 2012
431
Antimicrobial antibodies are associated with a Crohn's disease-like phenotype after ileal pouch-anal anastomosis. 38
21963956 2012
432
Efficacy of infliximab rescue therapy in patients with chronic refractory pouchitis: a multicenter study. 38
21826765 2012
433
Increased crypt apoptosis is a feature of autoimmune-associated chronic antibiotic refractory pouchitis. 38
22513433 2012
434
[Diagnosis and treatment of pouchitis and pouch dysfunction]. 38
22539393 2012
435
Acute and chronic pouchitis--pathogenesis, diagnosis and treatment. 38
22508158 2012
436
Preventing bacteria-induced disease with bacteria. 38
22378800 2012
437
Octreotide for the treatment of diarrhoea in patients with ileal pouch anal anastomosis: a placebo-controlled crossover study. 38
21951549 2012
438
Discrepancy between clinical and histological effects of DHA supplementation in a rat model of pouchitis. 38
22532147 2012
439
Genetic risk profiling and gene signature modeling to predict risk of complications after IPAA. 38
22469789 2012
440
The long-term clinical course of pouchitis after total proctocolectomy and IPAA for ulcerative colitis. 38
22469801 2012
441
Single-incision laparoscopic colon and rectal surgery for pediatric inflammatory bowel disease and polyposis syndromes. 38
22047143 2012
442
Prediction of late-onset pouch failure in patients with restorative proctocolectomy with a nomogram. 38
22325174 2012
443
Evaluation of upper and lower gastrointestinal histology in patients with ileal pouches. 38
22052108 2012
444
Seroreactivity to E. coli outer membrane protein C antibodies in active inflammatory bowel disease; diagnostic value and correlation with phylogroup B2 E. coli infection. 38
22150030 2012
445
[Diagnosis and management of pouchitis]. 38
23126134 2012
446
[Probiotics have a limited role in the treatment of inflammatory bowel disease]. 38
23031240 2012
447
Advances in the surgical management of inflammatory bowel disease. 38
22134218 2012
448
A meta-analysis of probiotic efficacy for gastrointestinal diseases. 38
22529959 2012
449
Pediatric chronic ulcerative colitis: does infliximab increase post-ileal pouch anal anastomosis complications? 38
22244417 2012
450
Pouchitis may increase the risk of dysplasia after restorative proctocolectomy in patients with ulcerative colitis. 38
21689264 2012
451
Restorative proctocolectomy without diverting ileostomy in children with ulcerative colitis. 38
22244418 2012
452
Risk factors for complications after total colectomy in ulcerative colitis. 38
23161324 2012
453
Rate and predictive factors of post-IPAA Crohn's-like disease (with or without pouchitis) in patients with ulcerative colitis. 38
23576088 2012
454
Bacteriology in the etiopathogenesis of pouchitis. 38
22796796 2012
455
Trace elements and rat pouchitis. 38
23198279 2012
456
The role of antibiotics and probiotics in pouchitis. 38
24714229 2012
457
The role of probiotics in pouchitis Georgios Nalmpantidis, Theofanis Maris. 38
24714248 2012
458
Innate immune environment in ileal pouch mucosa: α5 defensin up-regulation as predictor of chronic/relapsing pouchitis. 38
21983950 2012
459
CD10 immunohistochemistry stains enteric mucosa, but negative staining is unreliable in the setting of active enteritis. 38
21804528 2011
460
[Clinical evaluation of restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis]. 38
22333105 2011
461
Ileal pouch and related complications: spectrum of imaging findings with emphasis on MRI. 38
21293855 2011
462
Tissue infiltration of IgG4+ plasma cells in symptomatic patients with ileal pouch-anal anastomosis. 38
22115377 2011
463
Ileal pouch anal anastomosis: an overview of surgery, recovery, and achieving postsurgical continence . 38
22156175 2011
464
Probiotics in the management of gastrointestinal disease: analysis of the attitudes and prescribing practices of gastroenterologists and surgeons. 38
22118700 2011
465
Efficacy and safety of endoscopic treatment of ileal pouch strictures. 38
21351202 2011
466
Transmural inflammation is not pathognomonic for Crohn's disease of the pouch. 38
21660630 2011
467
Refractory ulcerative chronic pouchitis in a patient with Gardner syndrome following restorative proctocolectomy with ileal pouch-anal anastomosis. 38
22149567 2011
468
Rifaximin in the treatment of inflammatory bowel disease. 38
22180705 2011
469
Backwash ileitis does not affect pouch outcome in patients with ulcerative colitis with restorative proctocolectomy. 38
21806956 2011
470
Cost-effectiveness analysis of adjunct VSL#3 therapy versus standard medical therapy in pediatric ulcerative colitis. 38
21694634 2011
471
Probiotics in the treatment of human inflammatory bowel diseases: update 2011. 38
21992953 2011
472
Are we reporting ileal pouch biopsies correctly? 38
20958905 2011
473
Clostridium difficile pouchitis after proctocolectomy with ileal pouch-anal anastomosis. 38
22196625 2011
474
Outcome after restorative proctocolectomy in children and adolescents. 38
20796002 2011
475
Small bowel lesions detected with wireless capsule endoscopy in patients with active ulcerative colitis and with post-proctocolectomy. 38
21951090 2011
476
The prognosis of clinical course and the analysis of the frequency of the inflammation and dysplasia in the intestinal J-pouch at the patients after restorative proctocolectomy due to FAP. 38
21559820 2011
477
Prevalence and clinical implications of positive serum anti-microsomal antibodies in symptomatic patients with ileal pouches. 38
21717284 2011
478
Elevated serum IgG4 is associated with chronic antibiotic-refractory pouchitis. 38
21725838 2011
479
Primary sclerosing cholangitis is associated with endoscopic and histologic inflammation of the distal afferent limb in patients with ileal pouch-anal anastomosis. 38
21830267 2011
480
How to manage pouchitis in ulcerative colitis? 38
21466487 2011
481
Impact of capsule endoscopy on management of inflammatory bowel disease: a single tertiary care center experience. 38
21830264 2011
482
Pharmacotherapy for acute pouchitis. 38
21775695 2011
483
Depression and mucosal proinflammatory cytokines are associated in patients with ulcerative colitis and pouchitis - A pilot study. 38
21683306 2011
484
TLR2 and TLR4 up-regulation and colonization of the ileal mucosa by Clostridiaceae spp. in chronic/relapsing pouchitis. 38
21601883 2011
485
Relationship between mucosa-associated microbiota and inflammatory parameters in the ileal pouch after restorative proctocolectomy for ulcerative colitis. 38
21549404 2011
486
[Intensive care and inflammatory bowel diseases (IBD). The severe and fulminant flare]. 38
21660632 2011
487
Irritable bowel syndrome, gut microbiota and probiotics. 38
21860817 2011
488
The clinical impact of primary sclerosing cholangitis in patients with an ileal pouch-anal anastomosis for ulcerative colitis. 38
21279368 2011
489
Distinct microbiome in pouchitis compared to healthy pouches in ulcerative colitis and familial adenomatous polyposis. 38
20845425 2011
490
Surgical prophylaxis of pouchitis in ulcerative colitis. 38
21127981 2011
491
Inflammatory bowel disease-associated colorectal cancer: proctocolectomy and mucosectomy do not necessarily eliminate pouch-related cancer incidences. 38
21311893 2011
492
IgG4-associated pouchitis. 38
20722051 2011
493
Outcome and long-term function of restorative proctocolectomy for Crohn's disease: comparison to patients with ulcerative colitis. 38
20002692 2011
494
An open study of maintenance antibiotic therapy for chronic antibiotic-dependent pouchitis: efficacy, complications and outcome. 38
20041929 2011
495
Irritable pouch syndrome is characterized by visceral hypersensitivity. 38
20684016 2011
496
Pouch-related dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. 38
21287223 2011
497
Laparoscopic proctocolectomy: analysis of long term complications. Case report. 38
21682107 2011
498
Intestinal pouch complications in patients who underwent restorative proctocolectomy for ulcerative colitis and familial adenomatous polyposis in 1985-2008. 38
22166319 2011
499
Small intestine and microbiota. 38
21102323 2011
500
Pouch function and gastrointestinal complications during pregnancy after ileal pouch-anal anastomosis. 38
20608799 2011
501
Perioperative factors during ileal pouch-anal anastomosis predict pouchitis. 38
21304302 2011
502
The diameter of the ileal J-pouch-anal anastomosis as an important risk factor of pouchitis - clinical observations. 38
21278694 2011
503
Probiotics in inflammatory bowel diseases and associated conditions. 38
22254095 2011
504
Natural history of cytomegalovirus infection in a series of patients diagnosed with moderate-severe ulcerative colitis. 38
21350712 2011
505
Risk of cancer in patients with chronic pouchitis after restorative proctocolectomy for ulcerative colitis. 38
19832871 2011
506
Long-Term Followup of Patients with Active J-Reservoirs after Restorative Proctocolectomy for Ulcerative Colitis with regard to Reservoir Function, Mucosal Changes, and Quality of Life. 38
21991508 2011
507
Long-term followup with evaluation of the surgical and functional results of the ileal pouch reservoir in restorative proctocolectomy for ulcerative colitis. 38
21991523 2011
508
Restorative proctocolectomy with and without protective ileostomy in a pediatric population. 38
21238667 2011
509
Gut microbial diversity is reduced by the probiotic VSL#3 and correlates with decreased TNBS-induced colitis. 38
20564535 2011
510
Gut microbiota and inflammatory bowel disease. 38
22179210 2011
511
Differential expression of TLR2, TLR4 and JNK in mucosa of ileal pouches for ulcerative colitis. Is there a role for bacterial antigen pathway in asymptomatic patients? 38
21977230 2011
512
Functional outcome and quality of life after restorative proctocolectomy and ileal pouch-anal anastomosis. 38
22286626 2011
513
One-year infliximab administration for the treatment of chronic refractory pouchitis. 38
24713783 2011
514
Inulin supplementation in rat model of pouchitis. 38
21887407 2011
515
Infliximab and/or azathioprine in the treatment of Crohn's disease-like complications after IPAA. 38
21160308 2011
516
Diagnosis and management of pouchitis and ileoanal pouch dysfunction. 38
20890738 2010
517
Early diagnosis of bilateral sub-deltoid bursitis using clinic-based ultrasonography in a patient receiving infliximab therapy for ulcerative pouchitis. 38
18949534 2010
518
Diagnosis and management of postoperative ileal pouch disorders. 38
22131896 2010
519
Morphologic findings in upper gastrointestinal biopsies of patients with ulcerative colitis: a controlled study. 38
20962621 2010
520
NOD2/CARD15 mutations correlate with severe pouchitis after ileal pouch-anal anastomosis. 38
20940596 2010
521
The bacterial pathogenesis and treatment of pouchitis. 38
21180613 2010
522
Ileal pouch dysfunction. 38
20725759 2010
523
Stasis predisposes ileal pouch inflammation in a rat model of ileal pouch-anal anastomosis. 38
19691981 2010
524
Treatment of relapsing mild-to-moderate ulcerative colitis with the probiotic VSL#3 as adjunctive to a standard pharmaceutical treatment: a double-blind, randomized, placebo-controlled study. 38
20517305 2010
525
Diagnosis and clinical course of ulcerative gastroduodenal lesion associated with ulcerative colitis: possible relationship with pouchitis. 38
21175478 2010
526
Quality of life ten and more years after restorative proctocolectomy for patients with familial adenomatous polyposis coli. 38
20847619 2010
527
Clinical implication of false-positive celiac serology in patients with ileal pouch. 38
20847628 2010
528
A role for B₁₂ in inflammatory bowel disease patients with suppurative dermatoses? An experience with high dose vitamin B₁₂ therapy. 38
21122544 2010
529
Long-term function after ileal pouch-anal anastomosis - function does not deteriorate with time. 38
20345969 2010
530
Clinical utility of C-reactive protein in patients with ileal pouch anal anastomosis. 38
20186934 2010
531
Outcomes of laparoscopic and open total colectomy in the pediatric population. 38
20822419 2010
532
Extended spectrum beta-lactamase-producing bacteria and Clostridium difficile in patients with pouchitis. 38
20626734 2010
533
Use of probiotics in gastrointestinal disorders: what to recommend? 38
21180611 2010
534
Complete resolution of intractable pouchitis in an obese patient following laparoscopic gastric banding. 38
19751231 2010
535
Evaluation of endoscopic and imaging modalities in the diagnosis of structural disorders of the ileal pouch. 38
20049948 2010
536
Functional outcome and quality of life following restorative proctocolectomy for ulcerative colitis in Indians. 38
20532530 2010
537
[Better quality of life after surgery treatment in patients with colitis ulcerosa: what is the price]. 38
20656664 2010
538
Postoperative outcome of colectomy for pediatric patients with ulcerative colitis. 38
20410838 2010
539
The bacteriology of pouchitis: a molecular phylogenetic analysis using 16S rRNA gene cloning and sequencing. 38
20562611 2010
540
Primary sclerosing cholangitis and extraintestinal manifestations in patients with ulcerative colitis and ileal pouch-anal anastomosis. 38
20480253 2010
541
A prospective analysis of clinical variables, serologic factors, and outcome of ileal pouch-anal anastomosis in patients with backwash ileitis. 38
20551749 2010
542
Ileal reservoir with ileo-anal anastomosis: long-term complications. 38
20832385 2010
543
Activation of signal transducer and activator of transcription-1 (STAT-1) and differential expression of interferon-gamma and anti-inflammatory proteins in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. 38
20345984 2010
544
Treatment and prevention of pouchitis after ileal pouch-anal anastomosis for chronic ulcerative colitis. 38
20556748 2010
545
Nutrition considerations surrounding restorative proctocolectomy. 38
20581318 2010
546
The role of intestinal microbiota in the development and severity of chemotherapy-induced mucositis. 38
20523891 2010
547
Asymmetric endoscopic inflammation of the ileal pouch: a sign of ischemic pouchitis? 38
19998461 2010
548
In search of an effective animal model to study the nemesis of the IBD surgeon--pouchitis after IPAA. 38
20070979 2010
549
Natural history of Crohn's disease in patients who underwent intentional restorative proctocolectomy with ileal pouch-anal anastomosis. 38
20047579 2010
550
Pyloric gland metaplasia and pouchitis in patients with ileal pouch-anal anastomoses. 38
20121720 2010
551
The role of pouch compliance measurement in the management of pouch dysfunction. 38
19924421 2010
552
Preoperative wireless capsule endoscopy does not predict outcome after ileal pouch-anal anastomosis. 38
20173476 2010
553
Fecal calprotectin mirrors inflammation of the distal ileum and bowel function after restorative proctocolectomy for pediatric-onset ulcerative colitis. 38
19685453 2010
554
Probiotics. 38
20208051 2010
555
Guidance for substantiating the evidence for beneficial effects of probiotics: probiotics in chronic inflammatory bowel disease and the functional disorder irritable bowel syndrome. 38
20107148 2010
556
[Impact of nutritional treatment in the evolution of inflammatory bowel disease]. 38
20449527 2010
557
[Usefulness of probiotics in prevention and therapy]. 38
20165999 2010
558
Efficacy of infliximab in refractory pouchitis and Crohn's disease-related complications of the pouch: a Belgian case series. 38
19637335 2010
559
Long-term outcome 10 years or more after restorative proctocolectomy and ileal pouch-anal anastomosis in patients with ulcerative colitis. 38
19280217 2010
560
Successful long-term use of infliximab in refractory pouchitis in an adolescent. 38
21274444 2010
561
Pouchitis and pouch dysfunction. 38
19944799 2010
562
Rigorous histopathological assessment of the colectomy specimen in patients with inflammatory bowel disease unclassified does not predict outcome after ileal pouch-anal anastomosis. 38
19755970 2010
563
[Familial adenomatous polyposis: a follow-up of the extracolonic manifestations]. 38
20578576 2010
564
Detection of epithelial apoptosis in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. 38
20113505 2010
565
Ileal pouch-anal anastomosis surgery: imaging and intervention for post-operative complications. 38
20083595 2010
566
Secondary pouchitis: those with identifiable etiopathogenetic or triggering factors. 38
19755972 2010
567
[Guideline 'Diagnosis and treatment of inflammatory bowel disease in adults'. I. Diagnosis and treatment]. 38
21029496 2010
568
Rifaximin: a unique gastrointestinal-selective antibiotic for enteric diseases. 38
19881343 2010
569
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis. 38
19817724 2010
570
Antibiotics and probiotics in chronic pouchitis: a comparative proteomic approach. 38
20039446 2010
571
Bacterial community diversity in cultures derived from healthy and inflamed ileal pouches after restorative proctocolectomy. 38
19637361 2009
572
Pouchitis and pouch dysfunction. 38
19913207 2009
573
Successful treatment for pouchitis with rebamipide refractory to a combination of metronidazole (MNZ) and ciprofloxacin (CFX). 38
26192795 2009
574
Outcome of salvage surgery for ileal pouches referred with a diagnosis of Crohn's disease. 38
19934917 2009
575
Evaluation of association between precolectomy thrombocytosis and the occurrence of inflammatory pouch disorders. 38
19966641 2009
576
Restorative proctocolectomy. Does ethnicity affect outcome? 38
19175647 2009
577
Are inflammatory bowel disease (IBD) and pouchitis a reactive enteropathy to group D streptococci (Enterococci)? 38
19097162 2009
578
Inflamed pouch mucosa possesses altered tight junctions indicating recurrence of inflammatory bowel disease. 38
19488769 2009
579
Pros and cons of antibiotic therapy for pouchitis. 38
19817675 2009
580
Laboratory tests for patients with ileal pouch-anal anastomosis: clinical utility in predicting, diagnosing, and monitoring pouch disorders. 38
19603012 2009
581
Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease. 38
19550410 2009
582
Comparison of outcomes after hand-sewn versus stapled ileal pouch-anal anastomosis in 3,109 patients. 38
19789032 2009
583
Restorative proctocolectomy and ileal pouch-anal anastomosis in children. 38
19690495 2009
584
Restorative proctocolectomy for inflammatory bowel disease: the Padova prognostic score for colitis in predicting long-term outcome and quality of life. 38
19415309 2009
585
Clinical guidelines for the management of pouchitis. 38
19685489 2009
586
Use of probiotics in the management of chemotherapy-induced diarrhea: a case study. 38
19423769 2009
587
Fulminant Clostridium difficile-associated pouchitis with a fatal outcome. 38
19654602 2009
588
Clinical features of ileal pouch-anal anastomosis in African American patients with underlying ulcerative colitis. 38
19485976 2009
589
Confocal laser endomicroscopy for the detection of mucosal changes in ileal pouch after restorative proctocolectomy. 38
19013113 2009
590
An assessment of bacterial dysbiosis in pouchitis using terminal restriction fragment length polymorphisms of 16S ribosomal DNA from pouch effluent microbiota. 38
19617766 2009
591
Colorectal cancer and inflammatory bowel disease: epidemiology, risk factors, mechanisms of carcinogenesis and prevention strategies. 38
19596953 2009
592
Pouchitis: lessons for inflammatory bowel disease. 38
19349860 2009
593
Selective upregulation of endothelial E-selectin in response to Helicobacter pylori-induced gastritis. 38
19414551 2009
594
Outcomes in pediatric patients undergoing straight vs J pouch ileoanal anastomosis: a multicenter analysis. 38
19573671 2009
595
[Pouchitis]. 38
19578307 2009
596
Development of pouchitis with combination therapy with peg-interferon alpha-2b and ribavirin for chronic hepatitis C in a patient with ulcerative colitis who underwent pouch surgery. 38
19491886 2009
597
Bacteriotherapy for inflammatory bowel disease: therapeutic tool and/or pharmacological vectors? 38
20117346 2009
598
Pathologic features of ulcerative colitis in patients with primary sclerosing cholangitis: a case-control study. 38
19295408 2009
599
The efficacy and tolerability of AST-120 (spherical carbon adsorbent) in active pouchitis. 38
19436282 2009
600
Proctocolectomy for ulcerative colitis after liver transplantation for primary sclerosing cholangitis. 38
19460568 2009
601
Faecal M2-pyruvate kinase: a novel, noninvasive marker of ileal pouch inflammation. 38
19300275 2009
602
Do probiotics have a role in the management of inflammatory bowel disease? 38
19772038 2009
603
A prospective evaluation of the long-term outcome of ileal pouch-anal anastomosis in patients with inflammatory bowel disease-unclassified and indeterminate colitis. 38
19502850 2009
604
Incidence and short-term implications of prepouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. 38
19502851 2009
605
Long-term outcomes of restorative proctocolectomy in children with ulcerative colitis. 38
19403505 2009
606
Fecal coliform testing to identify effective antibiotic therapies for patients with antibiotic-resistant pouchitis. 38
19418603 2009
607
Re: Adenocarcinoma arising in a background of chronic atrophic pouchitis in an ileoanal pouch for ulcerative colitis. 38
19302532 2009
608
Pathogenesis of and unifying hypothesis for idiopathic pouchitis. 38
19259080 2009
609
Prevalence and outcome of anemia after restorative proctocolectomy: a clinical literature review. 38
19404082 2009
610
Association between immune-associated disorders and adverse outcomes of ileal pouch-anal anastomosis. 38
19262522 2009
611
Prebiotics in chronic intestinal inflammation. 38
18831524 2009
612
Diagnostic value of esophagogastroduodenoscopy in patients with ileal pouch-anal anastomosis. 38
18972552 2009
613
Pouchitis, similar to active ulcerative colitis, is associated with impaired butyrate oxidation by intestinal mucosa. 38
18942762 2009
614
Risk factors for low bone mass in patients with ulcerative colitis following ileal pouch-anal anastomosis. 38
19262520 2009
615
Partially hydrolyzed guar gum attenuates the severity of pouchitis in a rat model of ileal J pouch-anal anastomosis. 38
18594969 2009
616
Administration of adalimumab in the treatment of Crohn's disease of the ileal pouch. 38
19183338 2009
617
Family history of Crohn's disease is associated with an increased risk for Crohn's disease of the pouch. 38
18798573 2009
618
An open study of antibiotics for the treatment of pre-pouch ileitis following restorative proctocolectomy with ileal pouch-anal anastomosis. 38
18945262 2009
619
Galectin-3 expression in pouchitis in patients with ulcerative colitis who underwent ileal pouch-anal anastomosis (IPAA). 38
19278794 2009
620
Pouchitis disease activity index (PDAI) does not predict patients with symptoms of pouchitis who will respond to antibiotics. 38
19882318 2009
621
Ileal J-pouch perforation at the blind end: report of a case. 38
19997806 2009
622
Prebiotics, probiotics and helminths: the 'natural' solution? 38
19786773 2009
623
Does mesorectal preservation protect the ileoanal anastomosis after restorative proctocolectomy? 38
18766412 2009
624
Accelerated infliximab infusions are safe and well tolerated in patients with inflammatory bowel disease. 38
19060632 2009
625
Probiotics for inflammatory bowel disease: a critical appraisal. 38
20203506 2009
626
Medical management of patients with ileal pouch anal anastomosis after restorative procto-colectomy. 38
19011577 2009
627
Pouchitis: an evolving clinical enigma--a review. 38
19273970 2009
628
Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. 38
19273980 2009
629
Optimizing conventional therapy for inflammatory bowel disease. 38
19006615 2008
630
Persistent perineal sinus after ileoanal pouch excision in inflammatory bowel diseases: incidence, risk factors, and clinical course. 38
18626712 2008
631
[Treatment of fistulating pouchitis with tumour necrosis factor-alpha-inhibitor (infliximab)]. 38
19091194 2008
632
Ileo-anal j-pouch cancer: an unusual case in an unusual location. 38
18545871 2008
633
Successful use of infliximab for treating fistulizing pouchitis with severe extraintestinal manifestation: a case report. 38
18452207 2008
634
Outcome of pouch surgery for ulcerative colitis: single center experience. 38
19260491 2008
635
A selective approach to restorative proctocolectomy without ileostomy: a single centre experience. 38
18355374 2008
636
Antisense inhibition of ICAM-1 expression as therapy provides insight into basic inflammatory pathways through early experiences in IBD. 38
18774928 2008
637
Juvenile polyposis syndrome. 38
20011494 2008
638
Predictors for acute and chronic pouchitis following restorative proctocolectomy for ulcerative colitis. 38
18005192 2008
639
Which therapies are advisable in pouchitis? 38
18816748 2008
640
Pouchitis and related conditions: a new association. 38
18834418 2008
641
[Oral budesonide in the treatment of chronic refractory pouchitis]. 38
18928746 2008
642
Application of wireless capsule endoscopy for the evaluation of iron deficiency anemia in patients with ileal pouches. 38
18360292 2008
643
Manipulation of intestinal microbial flora for therapeutic benefit in inflammatory bowel diseases: review of clinical trials of probiotics, pre-biotics and synbiotics. 38
18782075 2008
644
Adenocarcinoma arising in a background of chronic atrophic pouchitis in an ileoanal pouch for ulcerative colitis. 38
18647190 2008
645
Balsalazide plus high-potency probiotic preparation (VSL[sharp]3) in the treatment of acute mild-to-moderate ulcerative colitis and uncomplicated diverticulitis of the colon. 38
18806701 2008
646
Enterochromaffin cell hyperplasia in irritable pouch syndrome. 38
18702649 2008
647
[Reconstruction of proctocolectomy: which is the best surgical procedure?]. 38
18939461 2008
648
Is there any place for alimentary probiotics, prebiotics or synbiotics, for patients with inflammatory bowel disease? 38
18384087 2008
649
Proliferation of immature plasma cells in pouchitis mucosa in patients with ulcerative colitis. 38
18452202 2008
650
Chronic pouchitis is not related to small intestine bacterial overgrowth. 38
18452204 2008
651
Comprehensive pouch clinic concept for follow-up of patients after ileal pouch anal anastomosis: report of 3 years' experience in a tertiary referral center. 38
18338779 2008
652
Risk factors for pouch failure in patients with different phenotypes of Crohn's disease of the pouch. 38
18300279 2008
653
Proctocolectomy-ileal pouch-anal anastomosis for ulcerative colitis after liver transplantation for primary sclerosing cholangitis: a multi-institutional analysis. 38
18449613 2008
654
Ileal pouch-anal anastomosis and liver transplantation for ulcerative colitis complicated by primary sclerosing cholangitis. 38
18496886 2008
655
Recommendations for probiotic use--2008. 38
18542033 2008
656
An innovative technique for colorectal specimen retrieval: a new era of "natural orifice specimen extraction" (N.O.S.E). 38
18481149 2008
657
Clostridium difficile infection in patients with ileal pouch-anal anastomosis. 38
18467184 2008
658
Analysis of bacterial bowel communities of IBD patients: what has it revealed? 38
18275077 2008
659
Endoscopy in the management of patients after ileal pouch surgery for ulcerative colitis. 38
18464195 2008
660
Development of pouchitis following ileal pouch-anal anastomosis (IPAA) for ulcerative colitis: A role for serological markers and microbial pattern recognition receptor genes. 38
21172204 2008
661
Rationale for probiotic treatment strategies in inflammatory bowel disease. 38
19072384 2008
662
Rifaximin for maintenance therapy in antibiotic-dependent pouchitis. 38
18573211 2008
663
Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis. 38
18253951 2008
664
Tumor necrosis factor-alpha inhibitor-induced lupus-like syndrome presenting as fever of unknown origin in a liver transplant recipient: case report and concise review of the literature. 38
18589191 2008
665
Evaluation of tissue eosinophilia in the pouch and afferent limb in patients with restorative proctocolectomy. 38
18286609 2008
666
Severe complications of inflammatory bowel disease. 38
18387381 2008
667
Predictors of pouchitis after ileal pouch-anal anastomosis: a retrospective review. 38
18266037 2008
668
[Restorative proctocolectomy with an ileoanal pouch. Postoperative course and long-term functional results]. 38
18489884 2008
669
Diagnosis and treatment of pouchitis. 38
21904509 2008
670
Recent developments on the role of Clostridium difficile in inflammatory bowel disease. 38
18473400 2008
671
Review article: restorative proctocolectomy, indications, management of complications and follow-up--a guide for gastroenterologists. 38
18266993 2008
672
Short-term treatment with infliximab in chronic refractory pouchitis and ileitis. 38
18298639 2008
673
Probiotic administration in patients with ileal pouch-anal anastomosis for ulcerative colitis is associated with expansion of mucosal regulatory cells. 38
18240282 2008
674
Both preoperative perinuclear antineutrophil cytoplasmic antibody and anti-CBir1 expression in ulcerative colitis patients influence pouchitis development after ileal pouch-anal anastomosis. 38
18378498 2008
675
On the benefit of probiotics in the management of pouchitis in patients underwent ileal pouch anal anastomosis: a meta-analysis of controlled clinical trials. 38
17940902 2008
676
[Ileal pouch-anal anastomosis for ulcerative colitis: complications and long term functional results]. 38
18769789 2008
677
[Short-term and long-term postoperative complications after ileal pouch-anal anastomosis in familial adenomatous polyposis]. 38
18622462 2008
678
Complications and functional results after ileoanal pouch formation in obese patients. 38
18228111 2008
679
Differential expression of pro-inflammatory cytokines and a pro-apoptotic protein in pelvic ileal pouches for ulcerative colitis and familial adenomatous polyposis. 38
18512010 2008
680
Faecal calprotectin: a noninvasive diagnostic tool and marker of severity in pouchitis. 38
18301296 2008
681
Probiotics: sorting the evidence from the myths. 38
18312197 2008
682
Microbial influences in inflammatory bowel diseases. 38
18242222 2008
683
Gastroduodenitis associated with ulcerative colitis. 38
18373161 2008
684
Recent trends in the surgical management of inflammatory bowel disease. 38
18200663 2008
685
[Pouchitis--what do we know after 30 years?]. 38
19172832 2008
686
Primary sclerosing cholangitis, autoimmune hepatitis and overlap syndromes in inflammatory bowel disease. 38
18200656 2008
687
Impact of orthotopic liver transplant for primary sclerosing cholangitis on chronic antibiotic refractory pouchitis. 38
18065274 2008
688
Leukocytapheresis for the treatment of active pouchitis: a pilot study. 38
18648745 2008
689
Permanently increased mucosal permeability in patients with backwash ileitis after ileoanal pouch for ulcerative colitis. 38
18569988 2008
690
Outcome after proctocolectomy with ileal pouch-anal anastomosis for ulcerative colitis. 38
17973304 2008
691
Probiotics, immunomodulation, and health benefits. 38
18183940 2008
692
Gastrointestinal microbiology enters the metagenomics era. 38
18043225 2008
693
Review article: Probiotics in gastrointestinal and liver diseases. 38
18081657 2007
694
High-dose probiotics for the treatment of active pouchitis. 38
17934776 2007
695
Microbial host interactions in IBD: implications for pathogenesis and therapy. 38
18377803 2007
696
Effect of withdrawal of nonsteroidal anti-inflammatory drug use on ileal pouch disorders. 38
17410449 2007
697
Irritable pouch syndrome is associated with depressiveness and can be differentiated from pouchitis by quantification of mucosal levels of proinflammatory gene transcripts. 38
17712839 2007
698
Inulin and oligofructose in chronic inflammatory bowel disease. 38
17951505 2007
699
Pouchitis. 38
17948934 2007
700
Probiotics in the management of colonic disorders. 38
17991347 2007
701
Prebiotics in inflammatory bowel diseases. 38
17922967 2007
702
Evolution of the restorative proctocolectomy and its effects on gastrointestinal hormones. 38
17576578 2007
703
Rifaximin for the treatment of active pouchitis: a randomized, double-blind, placebo-controlled pilot study. 38
17567869 2007
704
Pouchitis atlas for objective endoscopic diagnosis. 38
17940832 2007
705
Portal vein thrombi after restorative proctocolectomy: serious complication without long-term sequelae. 38
17701370 2007
706
Probiotics for preventing relapse or recurrence in Crohn's disease involving the ileum: Are there reasons for failure? 38
21172184 2007
707
Clinical features and quality of life in patients with different phenotypes of Crohn's disease of the ileal pouch. 38
17665259 2007
708
Ileal pelvic pouch microbiota from two former ulcerative colitis patients, analysed by DNA-based methods, were unstable over time and showed the presence of Clostridium perfringens. 38
17613928 2007
709
A prospective multivariate analysis of clinical factors associated with pouchitis after ileal pouch-anal anastomosis. 38
17544871 2007
710
Complications of ileal pouch anal anastomosis. 38
17602976 2007
711
Evidence for the use of probiotics and prebiotics in inflammatory bowel disease: a review of clinical trials. 38
17637082 2007
712
Probiotics: an overview and their role in inflammatory bowel disease. 38
19858636 2007
713
Ileal pouch-anal anastomosis. 38
17571291 2007
714
Clinical features of ileal pouch polyps in patients with underlying ulcerative colitis. 38
17309000 2007
715
Elective and emergent operative management of ulcerative colitis. 38
17560416 2007
716
Mucosal dysplasia in ileal pelvic pouches after restorative proctocolectomy. 38
17429711 2007
717
Rifaximin: recent advances in gastroenterology and hepatology. 38
23329908 2007
718
[Ileo pouch-anal anastomosis]. 38
17393129 2007
719
Reoperations in Hirschsprung disease. 38
17560211 2007
720
Controlled study using wireless capsule endoscopy for the evaluation of the small intestine in chronic refractory pouchitis. 38
17509099 2007
721
Oral budesonide in the treatment of chronic refractory pouchitis. 38
17451569 2007
722
Immunomodulatory effects of ciprofloxacin in TNBS-induced colitis in mice. 38
17253612 2007
723
Systematic review of dysplasia after restorative proctocolectomy for ulcerative colitis. 38
17443850 2007
724
[Colectomy management]. 38
17679301 2007
725
[Probiotics and prebiotics in clinical practice]. 38
17679291 2007
726
Vascular endothelial growth factor and cyclooxygenase-2 are overexpressed in ileal pouch-anal anastomosis. 38
17195901 2007
727
Combined ciprofloxacin and tinidazole therapy in the treatment of chronic refractory pouchitis. 38
17279300 2007
728
[Pre- and probiotics]. 38
17323288 2007
729
Long-term function and manovolumetric characteristics after ileal pouch-anal anastomosis for ulcerative colitis. 38
17225209 2007
730
Dysbiosis in pouchitis: evidence of unique microfloral patterns in pouch inflammation. 38
17368235 2007
731
Dysbiosis and pouchitis (Br J Surg 2006; 93: 1325-1334). 38
17315277 2007
732
Possible role of human cytomegalovirus in pouchitis after proctocolectomy with ileal pouch-anal anastomosis in patients with ulcerative colitis. 38
17373744 2007
733
Ileal pouch-anal anastomosis: the Australasian experience. 38
17223938 2007
734
Medium-term results of oral tacrolimus treatment in refractory inflammatory bowel disease. 38
17206694 2007
735
Surgical complications in relation to functional outcomes after ileoanal anastomosis in pediatric patients with ulcerative colitis. 38
17270537 2007
736
Multicenter randomized-controlled clinical trial of probiotics (Lactobacillus johnsonii, LA1) on early endoscopic recurrence of Crohn's disease after lleo-caecal resection. 38
17206696 2007
737
Clinical outcomes and cost analysis of a "fast track" postoperative care pathway for ileal pouch-anal anastomosis: a case control study. 38
17186427 2007
738
Iron-deficiency anemia as presentation of pouchitis. 38
17198064 2007
739
Spotlight on VSL#3 probiotic mixture in chronic inflammatory bowel diseases. 38
17263590 2007
740
Pouch outcomes among children with ulcerative colitis treated with calcineurin inhibitors before ileal pouch anal anastomosis surgery. 38
17208537 2007
741
Risk of dysplasia and adenocarcinoma following restorative proctocolectomy for ulcerative colitis. 38
17181842 2007
742
Pouchitis and pre-pouch ileitis developed after restorative proctocolectomy for ulcerative colitis: a case report. 38
17278237 2007
743
Portal vein thrombi after ileal pouch-anal anastomosis: its incidence and association with pouchitis. 38
17593473 2007
744
Pouchography, CT, and MRI features of ileal J pouch-anal anastomosis. 38
17114511 2006
745
Long-acting octreotide in the treatment of diarrhea after pelvic pouch surgery. 38
17115310 2006
746
The role of antibiotic and probiotic therapies in current and future management of inflammatory bowel disease. 38
17105688 2006
747
The hazardous burden of Herpesviridae in inflammatory bowel disease: the case of refractory severe ulcerative colitis. 38
16931197 2006
748
Risk factors for clinical phenotypes of Crohn's disease of the ileal pouch. 38
17227523 2006
749
Clostridium difficile-associated pouchitis. 38
17103037 2006
750
Clinical usefulness of probiotics in inflammatory bowel diseases. 38
17242485 2006
751
Critical evaluation of probiotic activity of lactic acid bacteria and their effects. 38
17242483 2006
752
Dysbiosis and pouchitis. 38
17058325 2006
753
[Probiotics--should we change the treatment strategy for pouchitis?]. 38
17059804 2006
754
Probiotics and prebiotics in chronic inflammatory bowel diseases. 38
17009391 2006
755
Review article: the intestinal lumen as a therapeutic target in inflammatory bowel disease. 38
16961752 2006
756
Serum biochemical evaluation of patients with functional pouches ten to 20 years after restorative proctocolectomy. 38
16437210 2006
757
Review article: colon-saving medical therapy vs. colectomy in ulcerative colitis - the case for colectomy. 38
16961750 2006
758
MRI of complicated pouchitis. 38
16985109 2006
759
Diffuse gastroduodenitis and pouchitis associated with ulcerative colitis. 38
17007066 2006
760
Collagenous pouchitis. 38
16807149 2006
761
Review article: prebiotics in the gastrointestinal tract. 38
16918875 2006
762
Quality of life after proctocolectomy with ileoanal anastomosis for patients with ulcerative colitis. 38
16940876 2006
763
A comparison of adverse events and functional outcomes after restorative proctocolectomy for familial adenomatous polyposis and ulcerative colitis. 38
16830218 2006
764
Probiotics: do they help to control intestinal inflammation? 38
17057214 2006
765
[Probiotics in chronic inflammatory bowel disease]. 38
16995360 2006
766
Does smoking influence the risk of pouchitis following ileal pouch anal anastomosis for ulcerative colitis? 38
16803691 2006
767
Increased bacterial permeation in long-lasting ileoanal pouches. 38
16917229 2006
768
Adenocarcinoma of the ileoanal pouch for ulcerative colitis--a complication of severe chronic atrophic pouchitis? 38
16365680 2006
769
Postoperative maintenance therapy for inflammatory bowel disease. 38
16760753 2006
770
Use of antibiotics in the treatment of inflammatory bowel disease. 38
16804403 2006
771
Increased cytokine transcripts in pouchitis reflect the degree of inflammation but not the underlying entity. 38
16133004 2006
772
Anti-Saccharomyces cerevisiae antibodies are associated with the development of postoperative fistulas following ileal pouch-anal anastomosis. 38
16843878 2006
773
Role of fecal calprotectin as a biomarker of intestinal inflammation in inflammatory bowel disease. 38
16775498 2006
774
Antibiotics and probiotics in treatment of inflammatory bowel disease. 38
16733845 2006
775
Pre-pouch ileitis: a disease of the ileum in ulcerative colitis after restorative proctocolectomy. 38
16684084 2006
776
Bacterial and fungal microbiota in relation to probiotic therapy (VSL#3) in pouchitis. 38
16401690 2006
777
A phase II dose ranging, double-blind, placebo-controlled study of alicaforsen enema in subjects with acute exacerbation of mild to moderate left-sided ulcerative colitis. 38
16669956 2006
778
Safety and efficacy of two dose formulations of alicaforsen enema compared with mesalazine enema for treatment of mild to moderate left-sided ulcerative colitis: a randomized, double-blind, active-controlled trial. 38
16669955 2006
779
Tacrolimus is safe and effective in patients with severe steroid-refractory or steroid-dependent inflammatory bowel disease--a long-term follow-up. 38
16573777 2006
780
Infliximab and ulcerative colitis. 38
16548766 2006
781
Arthritis accompanying ileal pouchitis or undifferentiated HLA B27-related spondyloarthropathy? 38
16079994 2006
782
Systematic review: the management of pouchitis. 38
16611268 2006
783
Chronic pouchitis after ileal pouch-anal anastomosis for ulcerative colitis: effect on quality of life. 38
16627228 2006
784
Anatomic extent of colitis and disease severity are not predictors of pouchitis after restorative proctocolectomy for mucosal ulcerative colitis. 38
16528486 2006
785
Utility of the Nonabsorbed (<0.4%) Antibiotic Rifaximin in Gastroenterology and Hepatology. 38
28286448 2006
786
Recommendations for probiotic use. 38
16633136 2006
787
Probiotics in the treatment of inflammatory bowel disease. 38
16633133 2006
788
[Nutritional therapy in inflammatory bowel disease]. 38
16565660 2006
789
Probiotics and the gastrointestinal tract: where are we in 2005? 38
16521211 2006
790
Primary sclerosing cholangitis, inflammatory bowel disease, and colon cancer. 38
16496231 2006
791
Defensin expression in chronic pouchitis in patients with ulcerative colitis or familial adenomatous polyposis coli. 38
16534846 2006
792
Prognostic significance of superficial fissuring ulceration in patients with severe "indeterminate" colitis. 38
16434889 2006
793
Diagnosis and treatment of ileal pouch diseases in patients with underlying ulcerative colitis. 38
16423309 2006
794
Risk factors for diseases of ileal pouch-anal anastomosis after restorative proctocolectomy for ulcerative colitis. 38
16431309 2006
795
Postoperative joint symptoms: a risk factor for pouchitis in ulcerative colitis patients. 38
16717470 2006
796
Pouchitis in ulcerative colitis: correlation between predictors from colectomy specimens and clinico-histological features. 38
16864967 2006
797
Restorative proctocolectomy for pediatric patients with ulcerative colitis. 38
16440164 2006
798
Change in the bacterial flora of pouchitis. 38
16506376 2006
799
Restorative proctocolectomy and ileal pouch-anal anastomosis for familial adenomatous polyposis revisited. 38
16998670 2006
800
Toll-like receptor signaling mechanisms involved in dendritic cell activation: potential therapeutic control of T cell polarization. 38